Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G1B,Phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,49089,-0.0672004531933732,0.0256786221793727,-0.117530552664944,-0.0168703537218027,0.00887655881133322
PLA2G1B,Phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,45360,-0.0565701599500343,0.0292699215992876,-0.113939206284638,0.000798886384569424,0.0532858861484448
PLA2G1B,Phospholipase A2,Physical activities,X1070.Time spent watching television (TV),50672,-0.0302061603594768,0.0262388503654636,-0.0816343070757855,0.021221986356832,0.249660528730346
PLA2G1B,Phospholipase A2,Physical activities,X1080.Time spent using computer,45323,-0.00685412658275077,0.0274933312982736,-0.0607410559273671,0.0470328027618656,0.80313008500905
PLA2G1B,Phospholipase A2,Physical activities,X1090.Time spent driving,42718,-0.0182143827017462,0.0298697727072254,-0.0767591372079079,0.0403303718044155,0.542006427415724
PLA2G1B,Phospholipase A2,Lifestyle factors,X1160.Sleep duration,52217,-0.0426405005096044,0.0237633263323698,-0.0892166201210492,0.00393561910184041,0.0727629891712766
PLA2G1B,Phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34194,0.00209922201014028,0.0150587136837336,-0.0274158568099775,0.0316143008302581,0.889134995558381
PLA2G1B,Phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34194,0.0167048658871202,0.0135008588129507,-0.00975681738626312,0.0431665491605036,0.215998588261206
PLA2G1B,Phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34194,0.020265383214483,0.0161179806681263,-0.0113258588950445,0.0518566253240105,0.208669637271403
PLA2G1B,Phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34194,0.0101538652928526,0.0164264707705798,-0.0220420174174839,0.042349748003189,0.536497240412183
PLA2G1B,Phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34194,0.00996259743061999,0.0166292414957576,-0.022630715901065,0.042555910762305,0.549119376732353
PLA2G1B,Phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34194,0.033930361982685,0.0319412768802061,-0.0286745407025188,0.0965352646678889,0.288138015024644
PLA2G1B,Phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34194,0.00134872112394577,0.0317767448138301,-0.0609336987111612,0.0636311409590527,0.966145899603212
PLA2G1B,Phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34194,-0.0339493045245703,0.0245849908679672,-0.0821358866257861,0.0142372775766455,0.167342754317634
PLA2G1B,Phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34194,0.0134451329009231,0.0176142823976635,-0.0210788605984974,0.0479691264003436,0.445297869380777
PLA2G1B,Phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34194,-0.0143315952710868,0.0121325776854912,-0.0381114475346495,0.00944825699247594,0.237532656373677
PLA2G1B,Phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34194,0.0116514110117856,0.0169184843972046,-0.0215088184067355,0.0448116404303066,0.491041467031075
PLA2G1B,Phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34194,0.00160420500998327,0.0103366269044139,-0.018655583722668,0.0218639937426345,0.876669874936149
PLA2G1B,Phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34194,-0.00526105853453018,0.0129023306116659,-0.0305496265333954,0.020027509464335,0.68345860387805
PLA2G1B,Phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34194,0.0153404722029111,0.0184681265885319,-0.0208570559106115,0.0515380003164336,0.406194096516857
PLA2G1B,Phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34194,-0.00898883513194973,0.0175794886902577,-0.0434446329648549,0.0254669627009555,0.609134967892674
PLA2G1B,Phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34194,-0.0103333956892613,0.0245521466716654,-0.0584556031657254,0.0377888117872028,0.673855319720809
PLA2G1B,Phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34194,-0.00469251757177569,0.0226842927619764,-0.0491537313852494,0.039768696241698,0.83612197803071
PLA2G1B,Phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34194,-0.00969545972381947,0.0137551410377802,-0.0366555361578687,0.0172646167102298,0.480913717288006
PLA2G1B,Phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34194,0.0177034582888949,0.012847095583639,-0.00747684905503756,0.0428837656328274,0.168231078555115
PLA2G1B,Phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34194,-0.010830259739575,0.0171178603577276,-0.0443812660407211,0.022720746561571,0.526952451540972
PLA2G1B,Phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,34200,-0.0223574710691094,0.0430478694191146,-0.106731295130574,0.0620163529923553,0.603519414490057
PLA2G1B,Phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34197,0.00669333552883939,0.0429554173401186,-0.0774992824577931,0.0908859535154719,0.876177722573793
PLA2G1B,Phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34197,-0.0212888343969653,0.0457366098766661,-0.110932589755231,0.0683549209613001,0.641608221822183
PLA2G1B,Phospholipase A2,Health and medical history,X120098.Mobility problems today,34204,-0.0297949164764333,0.0501913115331459,-0.128169887081399,0.0685800541285328,0.552775406729804
PLA2G1B,Phospholipase A2,Health and medical history,X120099.Self-care problems today,34204,-0.00481515953932635,0.0791824794722769,-0.160012819304989,0.150382500226336,0.951511038872644
PLA2G1B,Phospholipase A2,Health and medical history,X120100.Problems doing usual activities,34204,0.0113153701308583,0.0476715342901647,-0.0821208370778645,0.104751577339581,0.812381615148188
PLA2G1B,Phospholipase A2,Health and medical history,X120101.Pain or discomfort today,34204,0.0743081178706408,0.0431788091312849,-0.0103223480266775,0.158938583767959,0.0852935327023437
PLA2G1B,Phospholipase A2,Health and medical history,X120102.Anxiety or depression today,34204,-0.00559675842050022,0.0504978335119746,-0.10457251210397,0.09337899526297,0.911752125035336
PLA2G1B,Phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,34166,-5.35071511459227e-05,0.00445850147443216,-0.00879217004103296,0.00868515573874111,0.990424942900797
PLA2G1B,Phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34179,-0.0328738897662166,0.05217260928069,-0.135132203956369,0.0693844244239359,0.528644858405376
PLA2G1B,Phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34156,-0.0235484483603425,0.0525527787352172,-0.126551894681368,0.0794549979606832,0.654097237807904
PLA2G1B,Phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34186,-0.00409523779683704,0.0424424621016687,-0.0872824635161077,0.0790919879224336,0.923134064376431
PLA2G1B,Phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34180,-0.0475109466554478,0.0435582210364529,-0.132885059886895,0.0378631665759998,0.275411772518595
PLA2G1B,Phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34189,-0.049673751462845,0.0528047995156162,-0.153171158513453,0.0538236555877629,0.346879275441422
PLA2G1B,Phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34158,-0.0687066426853234,0.0551216940235641,-0.176745162971509,0.0393318776008621,0.212627942995343
PLA2G1B,Phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34184,0.0356596595368729,0.0568655197713543,-0.0757967592149816,0.147116078288727,0.530616560624116
PLA2G1B,Phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34175,0.0266479445126237,0.0826051378648386,-0.13525812570246,0.188554014727707,0.747009468177783
PLA2G1B,Phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34136,-0.237632639206122,0.11057933268087,-0.454368131260628,-0.0208971471516159,0.0316607976563253
PLA2G1B,Phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31789,0.00297421634295451,0.0560862593041812,-0.106954851893241,0.11290328457915,0.9577099885516
PLA2G1B,Phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49842,-0.0952364702016272,0.0566061751068101,-0.206184573410975,0.0157116330077206,0.0924959258298137
PLA2G1B,Phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47967,-0.0863305902789228,0.0373498915257075,-0.15953637766931,-0.013124802888536,0.0208192975389336
PLA2G1B,Phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51675,-0.0578954527764669,0.024684592352812,-0.106277253787978,-0.00951365176495534,0.019013382414776
PLA2G1B,Phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,51168,-0.00606737056992762,0.0266069678706384,-0.0582170275963789,0.0460822864565237,0.819619296453175
PLA2G1B,Phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51719,0.179669891920572,0.0256838821003758,0.129329483003835,0.230010300837309,2.70543604592697e-12
PLA2G1B,Phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,49943,0.149041336071369,0.0258790629874585,0.0983183726159507,0.199764299526788,8.55110912193144e-09
PLA2G1B,Phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52508,-0.0241515020921207,0.0420115552956883,-0.10649415047167,0.0581911462874283,0.565378690254252
PLA2G1B,Phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52508,-0.00998751309913023,0.0247359703503554,-0.0584700149858268,0.0384949887875664,0.686388791125808
PLA2G1B,Phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52508,-0.0756868492620458,0.0248226801893772,-0.124339302433225,-0.0270343960908664,0.00229741417474177
PLA2G1B,Phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52508,-0.0427385674188642,0.0241995602213066,-0.090169705452625,0.00469257061489667,0.0773918597053249
PLA2G1B,Phospholipase A2,Diet and food preferences,X1438.Bread intake,51550,0.000267065686048726,0.00310626299994131,-0.00582120979383625,0.0063553411659337,0.931485716833514
PLA2G1B,Phospholipase A2,Diet and food preferences,X1458.Cereal intake,51092,0.270485568871087,0.0245605334046334,0.222346923398006,0.318624214344169,3.80402537129522e-28
PLA2G1B,Phospholipase A2,Diet and food preferences,X1488.Tea intake,51572,0.0248810854145345,0.00288828639831781,0.0192200440738316,0.0305421267552374,7.40121935356381e-18
PLA2G1B,Phospholipase A2,Diet and food preferences,X1498.Coffee intake,50277,-0.0684882945902437,0.024655942330694,-0.116813941558404,-0.0201626476220834,0.00547744872187391
PLA2G1B,Phospholipase A2,Diet and food preferences,X1528.Water intake,50747,-0.0583603997498497,0.025101025658352,-0.10755841004022,-0.00916238945947979,0.0200784348740599
PLA2G1B,Phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,41592,-0.114679357893239,0.0312251436969323,-0.175880639539226,-0.0534780762472514,0.000240768172504556
PLA2G1B,Phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41590,-0.151969952382557,0.0315100936035405,-0.213729735845496,-0.0902101689196176,1.42703030982101e-06
PLA2G1B,Phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,41616,-0.0643983721803072,0.0399279100908763,-0.142657075958425,0.0138603315978104,0.106791989425254
PLA2G1B,Phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,41543,-0.0915673094520755,0.0350840736175617,-0.160332093742496,-0.0228025251616547,0.00906372030939014
PLA2G1B,Phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,41622,0.0444204157936895,0.0531284605055201,-0.0597113667971299,0.148552198384509,0.403113355032415
PLA2G1B,Phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45824,0.00647556434531385,0.029371533446843,-0.0510926412104984,0.0640437699011261,0.825506647125807
PLA2G1B,Phospholipase A2,Health and medical history,X1807.Father's age at death,44929,0.00466084233087296,0.00336050145217828,-0.00192574051539647,0.0112474251771424,0.165472574556068
PLA2G1B,Phospholipase A2,Health and medical history,X1845.Mother's age,35396,0.0171541294809156,0.0073842368951079,0.00268102516650413,0.0316272337953271,0.0201934072358886
PLA2G1B,Phospholipase A2,Health and medical history,X1873.Number of full brothers,51982,-0.0201967190906016,0.0237557335513029,-0.0667579568511553,0.0263645186699521,0.395230786112886
PLA2G1B,Phospholipase A2,Health and medical history,X1883.Number of full sisters,51989,-0.014418099547575,0.023879127982585,-0.0612211903934416,0.0323849912982917,0.54598487713938
PLA2G1B,Phospholipase A2,Physical measures,X20015.Sitting height,52313,-0.0103655764598993,0.00382231238565662,-0.0178573087357863,-0.00287384418401235,0.00669478605896026
PLA2G1B,Phospholipase A2,Cognitive function,X20016.Fluid intelligence score,33435,0.061753303928457,0.0402673604726792,-0.0171707225979943,0.140677330454908,0.125167753737523
PLA2G1B,Phospholipase A2,Cognitive function,X20018.Prospective memory result,33777,-0.0938922284365307,0.0523420432921089,-0.196482633289064,0.00869817641600283,0.0728742194073114
PLA2G1B,Phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33306,-0.00340569417728659,0.00518029521141368,-0.0135590727916574,0.00674768443708422,0.510919981304661
PLA2G1B,Phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33284,-0.00381846957212543,0.00516539030359254,-0.0139426345671668,0.00630569542291594,0.459780164322694
PLA2G1B,Phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,52191,-0.00247187929381177,0.00312444325525714,-0.00859578807411576,0.00365202948649222,0.428867708655294
PLA2G1B,Phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49234,0.00521127005856286,0.00634414385730132,-0.00722325190174772,0.0176457920188734,0.411409285995604
PLA2G1B,Phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48794,-0.0127974160931751,0.0137731798811729,-0.0397928486602741,0.0141980164739238,0.352818085651626
PLA2G1B,Phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48767,0.0111333393023403,0.0187635138492573,-0.025643147842204,0.0479098264468847,0.552952164248225
PLA2G1B,Phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48782,0.00909168898217991,0.0150922777436645,-0.0204891753954025,0.0386725533597623,0.54690907638964
PLA2G1B,Phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48786,0.0114616148317148,0.0113360244621752,-0.0107569931141486,0.0336802227775781,0.311988734652285
PLA2G1B,Phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48952,0.00306893193387852,0.00823215677460234,-0.0130660953443421,0.0192039592120991,0.709301984553315
PLA2G1B,Phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48885,-0.00821829089282198,0.0103507596508814,-0.0285057798085495,0.0120691980229056,0.427215081249841
PLA2G1B,Phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48794,-0.014796367268349,0.0132122340814338,-0.0406923460679593,0.0110996115312613,0.262767869117223
PLA2G1B,Phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48944,-0.0349453159213829,0.00930404700226191,-0.0531812480458162,-0.0167093837969495,0.000173101193274085
PLA2G1B,Phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,49003,-0.00137583464059469,0.00705070845042989,-0.0151952232034373,0.0124435539222479,0.845289472243383
PLA2G1B,Phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48873,-0.00512643901654847,0.00984716112685911,-0.0244268748251923,0.0141739967920954,0.60264967846877
PLA2G1B,Phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50630,0.0213590578215472,0.00707931612135152,0.0074835982236982,0.0352345174193962,0.00255444426876672
PLA2G1B,Phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50494,0.0109235765428327,0.0103265568988884,-0.0093164749789887,0.031163628064654,0.290150057106763
PLA2G1B,Phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50426,0.0174097254085965,0.0221835826440333,-0.0260700965737088,0.0608895473909017,0.432576682718839
PLA2G1B,Phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50464,0.0194993401266947,0.0111409533407799,-0.00233692842123383,0.0413356086746232,0.080088730423573
PLA2G1B,Phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50560,-0.00745653610623078,0.00815809123365958,-0.0234463949242035,0.00853332271174199,0.360722663726444
PLA2G1B,Phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50449,-0.0588654749639021,0.015044662165637,-0.0883530128085506,-0.0293779371192536,9.14964382020381e-05
PLA2G1B,Phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50446,0.00749734741925083,0.0133121611495088,-0.0185944884337864,0.033589183272288,0.573306718420909
PLA2G1B,Phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50476,-0.00660213987099895,0.0106390220719129,-0.0274546231319483,0.0142503433899504,0.53489532087866
PLA2G1B,Phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50493,-0.0111655226980464,0.0118803203854171,-0.0344509506534639,0.0121199052573712,0.347311706491992
PLA2G1B,Phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50656,0.00975232580386086,0.00614963950851774,-0.00230096763283392,0.0218056192405556,0.112788358911531
PLA2G1B,Phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50507,-0.0224128947177202,0.00969859988419323,-0.0414221504907389,-0.00340363894470145,0.0208438662793803
PLA2G1B,Phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46964,0.00563672108255709,0.0100224140561046,-0.014007210467408,0.0252806526325222,0.573841274759736
PLA2G1B,Phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46818,-0.0572248695922021,0.0395670039872999,-0.13477619740731,0.0203264582229057,0.148113382807872
PLA2G1B,Phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46815,-0.00347269442388636,0.0411766544600056,-0.0841789371654974,0.0772335483177246,0.93278965742834
PLA2G1B,Phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46878,0.0149976779366918,0.0110861456779912,-0.00673116759217091,0.0367265234655546,0.176123369159099
PLA2G1B,Phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46830,0.0181661468509315,0.0234359995793934,-0.0277684123246796,0.0641007060265426,0.438265981921472
PLA2G1B,Phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46843,-0.0157222473123131,0.0171355422508921,-0.0493079101240615,0.0178634154994354,0.358878737227581
PLA2G1B,Phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46825,-0.0215380566795542,0.0207313473988234,-0.062171497581248,0.0190953842221397,0.298856643516883
PLA2G1B,Phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46823,-0.0217754095948696,0.0200931520234496,-0.0611579875608307,0.0176071683710916,0.278499345031175
PLA2G1B,Phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46840,-0.00519012000089567,0.0147631564336996,-0.0341259066109469,0.0237456666091556,0.72517235237284
PLA2G1B,Phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46844,-0.0173733399974157,0.0177736558727116,-0.0522097055079303,0.017463025513099,0.3283436140075
PLA2G1B,Phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47038,-0.00152375810267181,0.00741325934778263,-0.0160537464243258,0.0130062302189821,0.837148226630262
PLA2G1B,Phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46918,-0.0404422237627989,0.0106376697789038,-0.0612920565294504,-0.0195923909961474,0.000144031926941718
PLA2G1B,Phospholipase A2,Mental health,X20127.Neuroticism score,46514,0.0340011104305929,0.0248289882730382,-0.0146637065845619,0.0826659274457477,0.170884522336707
PLA2G1B,Phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33435,0.00777269808284756,0.0410959208277181,-0.0727753067394798,0.088320702905175,0.84999088626774
PLA2G1B,Phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,31941,-0.0102433620510949,0.00625067689937799,-0.0224946887738757,0.00200796467168601,0.101305160472042
PLA2G1B,Phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31941,-0.0117219038990609,0.00617113167491102,-0.0238173219818865,0.000373514183764717,0.0575405665045527
PLA2G1B,Phospholipase A2,Cognitive function,X20191.Fluid intelligence score,31581,0.137386168496473,0.0461589446391694,0.046914637003701,0.227857699989245,0.00292662598101324
PLA2G1B,Phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31581,0.0574427170235851,0.0473733667667023,-0.0354090818391515,0.150294515886322,0.225341023557115
PLA2G1B,Phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,30814,0.0738155408515538,0.0497880296803569,-0.0237689973219457,0.171400079025053,0.138231335377414
PLA2G1B,Phospholipase A2,Physical measures,X20255.Spirometry QC measure,46028,-0.0300287815152823,0.0334350366085001,-0.0955614532679426,0.0355038902373779,0.369129901578642
PLA2G1B,Phospholipase A2,Eye measures,X20261.avMSE,30542,-0.0162346740688604,0.00593896989677127,-0.0278750550665321,-0.0045942930711887,0.00628301036906725
PLA2G1B,Phospholipase A2,Eye measures,X20262.Myopia diagnosis,30542,0.166020434181904,0.061523049000359,0.0454352581412009,0.286605610222608,0.00698432172399115
PLA2G1B,Phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,40468,-0.047284128523793,0.00396501390323017,-0.0550555557741242,-0.0395127012734619,1.20052972903191e-32
PLA2G1B,Phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40507,-0.0234203762316787,0.0038123129767129,-0.0308925096660359,-0.0159482427973214,8.27037306034694e-10
PLA2G1B,Phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33272,0.00993825012725133,0.01847652177146,-0.0262757325448102,0.0461522327993129,0.590669784056214
PLA2G1B,Phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33269,-0.00117897182514328,0.0345315736624093,-0.0688608562034655,0.066502912553179,0.972764808905384
PLA2G1B,Phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33268,0.0506334488135943,0.0429906641200954,-0.0336282528617926,0.134895150488981,0.238917002764668
PLA2G1B,Phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33268,0.00553613624174067,0.0173379218170596,-0.0284461905196961,0.0395184630031774,0.749500571591379
PLA2G1B,Phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33268,-0.0691151208321948,0.0341764961779208,-0.13610105334092,-0.00212918832347,0.0431755283519771
PLA2G1B,Phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33275,-0.00553553874777845,0.0420099294759415,-0.0878750005206239,0.076803923025067,0.895171285353908
PLA2G1B,Phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33275,0.0220417888993491,0.0280300414756203,-0.0328970923928666,0.0769806701915648,0.431675943512798
PLA2G1B,Phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33275,0.0336936889564115,0.0306865182489512,-0.0264518868115328,0.0938392647243559,0.272235990285982
PLA2G1B,Phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33275,0.0263686831013439,0.050351705680307,-0.0723206600320578,0.125058026234746,0.600507348033009
PLA2G1B,Phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33275,0.0613084904117597,0.060767524821317,-0.0577958582380216,0.180412839061541,0.313049199921464
PLA2G1B,Phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33275,0.0638326681657541,0.0318968373496259,0.00131486696048734,0.126350469371021,0.0453989908394462
PLA2G1B,Phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33275,-0.0169498522659446,0.0612744653965447,-0.137047804443172,0.103148099911283,0.782077011397407
PLA2G1B,Phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33275,0.0138752615083872,0.041986650515909,-0.0684185735027945,0.0961690965195689,0.741053907254999
PLA2G1B,Phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33274,0.0248627521962849,0.049807482789885,-0.0727599140718898,0.12248541846446,0.617667110114061
PLA2G1B,Phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33274,0.00372763215259054,0.0234942626120028,-0.042321122566935,0.0497763868721161,0.873939297836977
PLA2G1B,Phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33274,-0.0758415787467152,0.0379498883704572,-0.150223359952811,-0.00145979754061903,0.0456967482046197
PLA2G1B,Phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33276,-0.0758972341135641,0.0561842344143002,-0.186018333565593,0.0342238653384643,0.176773785330296
PLA2G1B,Phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,35156,-0.0644369008909529,0.0380393180573014,-0.138993964283264,0.0101201625013577,0.0903029124439103
PLA2G1B,Phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,35156,-0.0313510200330362,0.0374938669323473,-0.104838999220437,0.0421369591543645,0.40308135443801
PLA2G1B,Phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,35156,0.0839951215143905,0.0378075728938139,0.00989227864251523,0.158097964386266,0.0263279487623704
PLA2G1B,Phospholipase A2,Diet and food preferences,X20603.Liking for apples,35156,0.0828943609400907,0.0386664257313118,0.00710816650671955,0.158680555373462,0.0320687468977102
PLA2G1B,Phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,35156,-0.0899316226048754,0.0391892261300291,-0.166742505819732,-0.0131207393900183,0.0217635900547622
PLA2G1B,Phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,35156,-0.059981037226434,0.0377870824722606,-0.134043718872065,0.0140816444191967,0.112464684492004
PLA2G1B,Phospholipase A2,Diet and food preferences,X20606.Liking for avocados,35156,-0.0992458212556137,0.0389230099500588,-0.175534920757729,-0.0229567217534985,0.0107923541063341
PLA2G1B,Phospholipase A2,Diet and food preferences,X20607.Liking for bacon,35156,-0.0815608763346386,0.0378871616572458,-0.15581971318284,-0.00730203948643679,0.031362104174924
PLA2G1B,Phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,35156,-0.00537969597671735,0.0385193414527465,-0.0808776052241004,0.0701182132706657,0.888929523335412
PLA2G1B,Phospholipase A2,Diet and food preferences,X20609.Liking for bananas,35156,0.0853357665061015,0.0396246661567024,0.00767142083896477,0.163000112173238,0.0312936640619396
PLA2G1B,Phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35156,-0.0735726329226113,0.0376712274355274,-0.147408238696245,0.000262972851022489,0.0508433554496775
PLA2G1B,Phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,35156,-0.0930542079225218,0.0378661019909723,-0.167271767824827,-0.0188366480202162,0.014008323764705
PLA2G1B,Phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,35156,-0.0538787691790391,0.0389027531439662,-0.130128165341213,0.0223706269831347,0.166093490829183
PLA2G1B,Phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,35156,-0.00313417754990968,0.0380222023298469,-0.0776576941164097,0.0713893390165903,0.934306168233627
PLA2G1B,Phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,35156,0.0190031164712897,0.0381536009688512,-0.0557779414276587,0.0937841743702382,0.618445824588676
PLA2G1B,Phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,35156,0.0852697285596853,0.0379665141208116,0.0108553608828946,0.159684096236476,0.0247295053062251
PLA2G1B,Phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,35156,-0.107833470062639,0.0379425629091315,-0.182200893364537,-0.0334660467607416,0.00449137061167251
PLA2G1B,Phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,35156,-0.0347492243151161,0.0395416788522576,-0.112250914865541,0.0427524662353088,0.379529511307357
PLA2G1B,Phospholipase A2,Diet and food preferences,X20618.Liking for black olives,35156,-0.0720751362680011,0.0383987266271697,-0.147336640457254,0.00318636792125139,0.0605427012270766
PLA2G1B,Phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,35156,-0.102677112651656,0.0387042490181737,-0.178537440727277,-0.026816784576036,0.00799298862311002
PLA2G1B,Phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,35156,-0.0599848759933908,0.0380042772609411,-0.134473259424835,0.0145035074380537,0.114509815322306
PLA2G1B,Phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,35156,-0.0714756305695561,0.0379388103488238,-0.145835698853251,0.00288443771413856,0.0595959571039476
PLA2G1B,Phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,35156,-0.00563462182592998,0.0377588646087005,-0.0796419964589829,0.0683727528071229,0.881377752686561
PLA2G1B,Phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,35156,-0.0247579865726782,0.0399383774257786,-0.103037206327204,0.0535212331818478,0.535333759498593
PLA2G1B,Phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,35156,0.114843937257571,0.0379686241346498,0.0404254339536575,0.189262440561485,0.00249465446479327
PLA2G1B,Phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,35156,-0.0250478481857734,0.0382959246989007,-0.100107860595619,0.0500121642240719,0.513086950007341
PLA2G1B,Phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),35156,-0.0628604391931552,0.0376544530226135,-0.136663167117478,0.0109422887311672,0.0950668989860252
PLA2G1B,Phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,35156,-0.0510817101394012,0.0378592653185432,-0.125285870163746,0.0231224498849434,0.177284424299406
PLA2G1B,Phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,35156,-0.00848495433610582,0.0385485028907391,-0.0840400200019543,0.0670701113297427,0.825788811918813
PLA2G1B,Phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,35156,0.0569450851277213,0.0380331946391941,-0.0175999763650992,0.131490146620542,0.134358520210903
PLA2G1B,Phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,35156,-0.0894163260597638,0.0385838647364625,-0.16504070094323,-0.0137919511762972,0.0204978036256548
PLA2G1B,Phospholipase A2,Diet and food preferences,X20631.Liking for cake,35156,0.161832174897111,0.0379477201724212,0.0874546433591651,0.236209706435056,2.01973695929501e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,35156,0.148449857467184,0.0375732821382656,0.0748062244761834,0.222093490458185,7.83443391085339e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20633.Liking for capers,35156,-0.136968088966162,0.0376282694640323,-0.210719497115665,-0.0632166808166584,0.000273890264776719
PLA2G1B,Phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,35156,-0.051397581027374,0.0389392286697143,-0.127718469220014,0.024923307165266,0.186882139518895
PLA2G1B,Phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,35156,0.0880240650616616,0.0378062073755753,0.0139238986055341,0.162124231517789,0.0199149045228338
PLA2G1B,Phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,35156,0.0503100773225134,0.0377154641245553,-0.023612232361615,0.124232387006642,0.182252697834423
PLA2G1B,Phospholipase A2,Diet and food preferences,X20637.Liking for cherries,35156,0.0768982957032491,0.0412702611365944,-0.003991416124476,0.157788007530974,0.0624494415198081
PLA2G1B,Phospholipase A2,Diet and food preferences,X20638.Liking for chicken,35156,-0.0442147832344098,0.0401315126188767,-0.122872547967408,0.0344429814985886,0.270596366958026
PLA2G1B,Phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,35156,-0.116536394523339,0.0382486391351265,-0.191503727228187,-0.0415690618184908,0.00231846530098814
PLA2G1B,Phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,35156,-0.0306166127185804,0.0381915225177878,-0.105471996853444,0.0442387714162836,0.422767519342027
PLA2G1B,Phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,35156,-0.0509015640947601,0.0629207212172769,-0.174226177680623,0.0724230494911027,0.418545020577517
PLA2G1B,Phospholipase A2,Diet and food preferences,X20642.Liking for cod,35156,-0.0322299784239234,0.0389353504646487,-0.108543265334635,0.0440833084867881,0.407812496542081
PLA2G1B,Phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,35156,0.0368670064749835,0.0433061820790006,-0.0480131103998577,0.121747123349825,0.394615967251236
PLA2G1B,Phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,35156,-0.0555671812285354,0.0387580816486026,-0.131533021259796,0.0203986588027257,0.151689191600378
PLA2G1B,Phospholipase A2,Diet and food preferences,X20645.Liking for coriander,35156,-0.0690868057522408,0.038056894154619,-0.143678318295294,0.00550470679081241,0.0694972342393377
PLA2G1B,Phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,35156,0.0570701646653567,0.0376364999276859,-0.0166973751929077,0.130837704523621,0.129460039999632
PLA2G1B,Phospholipase A2,Diet and food preferences,X20647.Liking for cream,35156,-0.0128089685047207,0.037668813513203,-0.0866398429905987,0.0610219059811572,0.733831780403265
PLA2G1B,Phospholipase A2,Diet and food preferences,X20648.Liking for croissant,35156,0.0324427262597803,0.0379360456357043,-0.0419119231862002,0.106797375705761,0.392462219178727
PLA2G1B,Phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,35156,-0.0769442032263724,0.0386641017027774,-0.152725842563816,-0.00116256388892867,0.0466088285219235
PLA2G1B,Phospholipase A2,Diet and food preferences,X20650.Liking for curry,35156,-0.0900684469163778,0.0385399949793093,-0.165606837075824,-0.0145300567569315,0.0194568948328269
PLA2G1B,Phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,35156,0.0534305020930305,0.0384765002768122,-0.0219834384495214,0.128844442635583,0.164967253724469
PLA2G1B,Phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,35156,0.0777170090583744,0.0382798350928331,0.00268853227642159,0.152745485840327,0.0423574927260432
PLA2G1B,Phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35156,-0.114744847036537,0.0395440869967033,-0.192251257550075,-0.0372384365229986,0.00371907990391071
PLA2G1B,Phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,35156,0.151261193780931,0.0382960056827657,0.07620102264271,0.226321364919152,7.8721672262596e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20655.Liking for eggs,35156,-0.0491027610890087,0.0391721174513479,-0.125880111293651,0.0276745891156332,0.210046447642332
PLA2G1B,Phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,35156,0.113130130593958,0.0377665071392173,0.0391077766010915,0.187152484586824,0.00274609756128511
PLA2G1B,Phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,35156,0.0627311847839808,0.0378202105594924,-0.0113964279126244,0.136858797480586,0.0972119714904214
PLA2G1B,Phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35156,-0.0490549546222089,0.0387003799030399,-0.124907699232167,0.0267977899877493,0.204983634112121
PLA2G1B,Phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,35156,-0.0749455473319175,0.0380013642219644,-0.149428221206968,-0.00046287345686738,0.0486147350884388
PLA2G1B,Phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,35156,-0.0879678026333877,0.0419792645923289,-0.170247161234352,-0.00568844403242309,0.036149483491134
PLA2G1B,Phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,35156,-0.0466810059911743,0.037881616707455,-0.120928974737786,0.0275669627554375,0.217869159442616
PLA2G1B,Phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,35156,-0.098593108339534,0.0380090537524454,-0.173090853694327,-0.024095362984741,0.00950131046218001
PLA2G1B,Phospholipase A2,Diet and food preferences,X20663.Liking for fruit,35156,0.0827184405169415,0.0439983935644505,-0.00351841086938152,0.168955291903265,0.0601307114589347
PLA2G1B,Phospholipase A2,Diet and food preferences,X20664.Liking for garlic,35156,-0.133472691028142,0.0385741436730372,-0.209078012627294,-0.0578673694289888,0.000541961734354923
PLA2G1B,Phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,35156,-0.069872440342633,0.0381070032287162,-0.144562166670917,0.0048172859856507,0.066743352323675
PLA2G1B,Phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,35156,-0.055490537857457,0.0375446573211405,-0.129078066206892,0.0180969904919784,0.139440545583883
PLA2G1B,Phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,35156,-0.0379325062195447,0.0377637388941894,-0.111949434452156,0.0360844220130666,0.315175316143777
PLA2G1B,Phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,35156,0.119390823804488,0.0383718556796342,0.0441819866724054,0.194599660936572,0.00186682372198245
PLA2G1B,Phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,35156,0.00273145229107691,0.0378250606664579,-0.0714056666151806,0.0768685711973344,0.94243393545091
PLA2G1B,Phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,35156,-0.176717509733473,0.0377972536255052,-0.250800126839463,-0.102634892627482,2.96961179322308e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,35156,0.0361319968770695,0.0377908504002565,-0.0379380699074333,0.110202063661572,0.339041122234473
PLA2G1B,Phospholipase A2,Diet and food preferences,X20672.Liking for green olives,35156,-0.0808457563251111,0.038391780123299,-0.156093645366777,-0.00559786728344507,0.0352441938824472
PLA2G1B,Phospholipase A2,Diet and food preferences,X20673.Liking for haddock,35156,-0.0670931034702387,0.0387017096097318,-0.142948454305313,0.00876224736483559,0.0830187270242485
PLA2G1B,Phospholipase A2,Diet and food preferences,X20674.Liking for ham,35156,-0.103292644653688,0.0379938135559203,-0.177760519223292,-0.0288247700840844,0.00656506436419949
PLA2G1B,Phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,35156,-0.0246658055477369,0.0387163205711929,-0.100549793867275,0.0512181827718013,0.524079440011525
PLA2G1B,Phospholipase A2,Diet and food preferences,X20676.Liking for herring,35156,-0.0565474751068118,0.0376463301193679,-0.130334282140773,0.0172393319271493,0.133108198032652
PLA2G1B,Phospholipase A2,Diet and food preferences,X20677.Liking for honey,35156,0.0599669197246351,0.0378121780827244,-0.0141449493175048,0.134078788766775,0.112788040625597
PLA2G1B,Phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35156,-0.153753936282005,0.0377370590422039,-0.227718572004725,-0.0797893005592853,4.64764949388509e-05
PLA2G1B,Phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,35156,0.137302344813437,0.03804153823329,0.0627409298761886,0.211863759750686,0.00030845759432355
PLA2G1B,Phospholipase A2,Diet and food preferences,X20680.Liking for jam,35156,0.111539681976751,0.0380559483938685,0.0369500231247693,0.186129340828734,0.0033865374827096
PLA2G1B,Phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,35156,0.041977714081076,0.0379766172681126,-0.0324564557644247,0.116411883926577,0.269029857560412
PLA2G1B,Phospholipase A2,Diet and food preferences,X20682.Liking for lager,35156,-0.130011282610537,0.0381723650888749,-0.204829118184732,-0.0551934470363422,0.000661887575674565
PLA2G1B,Phospholipase A2,Diet and food preferences,X20683.Liking for lamb,35156,-0.0594061746848835,0.0381527840197302,-0.134185631363555,0.0153732819937877,0.119485824586488
PLA2G1B,Phospholipase A2,Diet and food preferences,X20684.Liking for lemons,35156,-0.0682808768512777,0.0383013752055683,-0.143351572254192,0.0067898185516362,0.0746591903992907
PLA2G1B,Phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,35156,0.0808076343642595,0.0384241550736473,0.00549629041991076,0.156118978308608,0.0354853498153805
PLA2G1B,Phospholipase A2,Diet and food preferences,X20686.Liking for liver,35156,-0.0684075122683814,0.0379670445968478,-0.142822919678203,0.00600789514144022,0.0716112822848088
PLA2G1B,Phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,35156,-0.025570177375276,0.0378914589934726,-0.0998374370024823,0.0486970822519302,0.499800308853785
PLA2G1B,Phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,35156,0.108295635527717,0.0377700089373774,0.0342664180104572,0.182324853044977,0.00414879479636631
PLA2G1B,Phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,35156,-0.0832897867721704,0.0377967025382859,-0.157371323747211,-0.00920824979713004,0.027571908616963
PLA2G1B,Phospholipase A2,Diet and food preferences,X20690.Liking for melon,35156,0.0450265999353422,0.0398520172626756,-0.0330833538995019,0.123136553770186,0.258566908003228
PLA2G1B,Phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,35156,0.0910812184951028,0.0380282204584459,0.0165459063965489,0.165616530593657,0.0166331333074292
PLA2G1B,Phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,35156,0.00669071286283577,0.0395620173885455,-0.0708508412187134,0.084232266944385,0.865705760654901
PLA2G1B,Phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,35156,-0.0118644255001784,0.0379236707824969,-0.0861948202338722,0.0624659692335155,0.754400624091131
PLA2G1B,Phospholipase A2,Diet and food preferences,X20695.Liking for oranges,35156,0.0652621620835652,0.0390504555023482,-0.0112767307010373,0.141801054868168,0.0947061739603157
PLA2G1B,Phospholipase A2,Diet and food preferences,X20696.Liking for pasta,35156,0.00317211136635178,0.0386529993215156,-0.0725877673038188,0.0789319900365223,0.934595470999104
PLA2G1B,Phospholipase A2,Diet and food preferences,X20697.Liking for pears,35156,0.0653871847586366,0.0391303676391483,-0.011308335814094,0.142082705331367,0.0947492171330139
PLA2G1B,Phospholipase A2,Diet and food preferences,X20698.Liking for pizza,35156,0.0632328080337185,0.0379636028942722,-0.0111758536390549,0.137641469706492,0.0958190854129811
PLA2G1B,Phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,35156,0.0552539864522365,0.0384274861481282,-0.0200638863980947,0.130571859302568,0.150498303685708
PLA2G1B,Phospholipase A2,Diet and food preferences,X20700.Liking for plums,35156,0.102676656501741,0.0391135839458547,0.026014031967866,0.179339281035617,0.00867494405352368
PLA2G1B,Phospholipase A2,Diet and food preferences,X20701.Liking for pollock,35156,-0.0642708804200487,0.0378168193179128,-0.138391846283158,0.00985008544306043,0.0892481405489337
PLA2G1B,Phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,35156,-0.0447373118104688,0.0375989350482855,-0.118431224505108,0.0289566008841707,0.234129476752369
PLA2G1B,Phospholipase A2,Diet and food preferences,X20703.Liking for porridge,35156,0.0637465162269641,0.0393122372381753,-0.0133054687598596,0.140798501213788,0.104930532798161
PLA2G1B,Phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,35156,-0.0864104967617521,0.0382370588647723,-0.161355132136706,-0.0114658613867984,0.0238498143791579
PLA2G1B,Phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,35156,-0.0112464158819743,0.0384303443972877,-0.0865698909006582,0.0640770591367096,0.769799831858164
PLA2G1B,Phospholipase A2,Diet and food preferences,X20706.Liking for prawns,35156,-0.123721572313984,0.0389504011457923,-0.200064358559737,-0.047378786068231,0.00149545194064255
PLA2G1B,Phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,35156,0.00316111667955813,0.038713103301115,-0.0727165657906272,0.0790387991497435,0.934922627940713
PLA2G1B,Phospholipase A2,Diet and food preferences,X20708.Liking for red meat,35156,-0.110968830259337,0.0379935994148088,-0.185436285112362,-0.0365013754063115,0.00349948372281004
PLA2G1B,Phospholipase A2,Diet and food preferences,X20709.Liking for red wine,35156,-0.175316000191616,0.0378876538516116,-0.249575801740775,-0.101056198642458,3.74891651518932e-06
PLA2G1B,Phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35156,0.0265277880669834,0.0400452323621176,-0.051960867362767,0.105016443496734,0.50769996088237
PLA2G1B,Phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,35156,0.0208626947075865,0.0401678538828862,-0.0578662989028705,0.0995916883180435,0.60350106011684
PLA2G1B,Phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,35156,-0.0348083405451367,0.0379221535239013,-0.109135761451983,0.0395190803617098,0.358697500647108
PLA2G1B,Phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,35156,0.0163269085271531,0.0394088781048487,-0.0609144925583503,0.0935683096126565,0.678666246761994
PLA2G1B,Phospholipase A2,Diet and food preferences,X20714.Liking for salami,35156,-0.101269491150632,0.0377219495931632,-0.175204512353232,-0.0273344699480322,0.0072721978108982
PLA2G1B,Phospholipase A2,Diet and food preferences,X20715.Liking for salmon,35156,-0.0586045780738127,0.0406623516389633,-0.138302787286181,0.0210936311385554,0.149543595948563
PLA2G1B,Phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,35156,-0.0457366636178638,0.0378958851526545,-0.120012598517067,0.028539271281339,0.227496132853242
PLA2G1B,Phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,35156,0.00302090179188162,0.0378962241663989,-0.0712556975742603,0.0772975011580236,0.936465330707022
PLA2G1B,Phospholipase A2,Diet and food preferences,X20718.Liking for sardines,35156,-0.0411835942809073,0.0378652728606931,-0.115399529087866,0.0330323405260512,0.276780803648164
PLA2G1B,Phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),35156,-0.0696490349619584,0.0376668016112742,-0.143475966120056,0.00417789619613895,0.064473434728819
PLA2G1B,Phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,35156,-0.0620406052688254,0.0381012842980497,-0.136719122493003,0.012637911955352,0.103489163763389
PLA2G1B,Phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35156,-0.116267005360888,0.0382738404481264,-0.191283732639215,-0.0412502780825599,0.00238913006616065
PLA2G1B,Phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,35156,-0.0150404657035404,0.0379754273189239,-0.0894723032486313,0.0593913718415505,0.692070260415155
PLA2G1B,Phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,35156,-0.0554626621683005,0.0380779698617195,-0.130095483097271,0.0191701587606697,0.145268578534897
PLA2G1B,Phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,35156,-0.0323949810837944,0.037897287608359,-0.106673664796178,0.0418837026285893,0.392675479055051
PLA2G1B,Phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,35156,-0.0471895157946205,0.0378796650631118,-0.12143365931832,0.0270546277290786,0.212874532019714
PLA2G1B,Phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,35156,0.0163283111178566,0.0380122935144517,-0.0581757841704688,0.0908324064061821,0.66752917180604
PLA2G1B,Phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,35156,-0.0765525027297109,0.0382684373468087,-0.151558639929456,-0.00154636552996577,0.04548141944292
PLA2G1B,Phospholipase A2,Diet and food preferences,X20728.Liking for spinach,35156,-0.0502925993278752,0.0387873042363858,-0.126315715631191,0.0257305169754409,0.194788123390328
PLA2G1B,Phospholipase A2,Diet and food preferences,X20729.Liking for spirits,35156,-0.22270043142973,0.0382792569640266,-0.297727775079222,-0.147673087780237,6.13437495246182e-09
PLA2G1B,Phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,35156,0.0623996647707741,0.0432984208980928,-0.0224652401894877,0.147264569731036,0.149570637840018
PLA2G1B,Phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35156,-0.0278269637133602,0.0397986596429936,-0.105832336613628,0.0501784091869073,0.484446323836919
PLA2G1B,Phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,35156,0.192182070639588,0.0379681358769678,0.117764524320731,0.266599616958445,4.22519404703917e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,35156,0.0530554069720281,0.0388693130589942,-0.0231284466236005,0.129239260567657,0.172291509844297
PLA2G1B,Phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,35156,0.112712646029839,0.0504573447217689,0.0138162503751725,0.211609041684507,0.0255154830179567
PLA2G1B,Phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,35156,0.121100387137697,0.0406579545145651,0.0414107962891499,0.200789977986245,0.00290297452822343
PLA2G1B,Phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,35156,-0.0377663538745527,0.0378180593625739,-0.111889750225198,0.0363570424760922,0.317995206255239
PLA2G1B,Phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,35156,-0.0431815509684639,0.0381739396081168,-0.118002472600373,0.0316393706634451,0.258005209529981
PLA2G1B,Phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),35156,-0.0441661627896469,0.0378967082075666,-0.118443710876477,0.0301113852971836,0.243868812851983
PLA2G1B,Phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,35156,-0.0434152966914409,0.0441188256935945,-0.129888195050886,0.0430576016680044,0.325111336983309
PLA2G1B,Phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,35156,-0.0330186148516207,0.0381018327902244,-0.10769820712046,0.041660977417219,0.386186889432567
PLA2G1B,Phospholipase A2,Diet and food preferences,X20741.Liking for watching television,35156,0.00358080966196258,0.038319759335844,-0.0715259186362917,0.0786875379602169,0.925551382981489
PLA2G1B,Phospholipase A2,Diet and food preferences,X20742.Liking for whisky,35156,-0.141925588229885,0.0407278502321327,-0.221752174684865,-0.062099001774905,0.000494606132049748
PLA2G1B,Phospholipase A2,Diet and food preferences,X20743.Liking for white bread,35156,-0.0120563062648165,0.0376791092076113,-0.0859073603117347,0.0617947477821016,0.74899487457214
PLA2G1B,Phospholipase A2,Diet and food preferences,X20744.Liking for white rice,35156,-0.0126094619981773,0.0380259593810987,-0.0871403423851309,0.0619214183887762,0.740196747168118
PLA2G1B,Phospholipase A2,Diet and food preferences,X20745.Liking for white wine,35156,-0.196854079382103,0.0382327117975209,-0.271790194505244,-0.121917964258962,2.66763209739349e-07
PLA2G1B,Phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35156,0.0239585081340534,0.0386186138597256,-0.0517339750310088,0.0996509912991155,0.535015870611114
PLA2G1B,Phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,35156,0.0664606805510257,0.0379488107098159,-0.00791898844021355,0.140840349542265,0.0799187000573387
PLA2G1B,Phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,35156,0.00358729674569923,0.0402753024954648,-0.0753522961454117,0.0825268896368101,0.929028429300199
PLA2G1B,Phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,35156,0.106178451896976,0.0378230978373369,0.0320451801357952,0.180311723658156,0.00500586898865209
PLA2G1B,Phospholipase A2,Physical measures,X21001.Body mass index (BMI),52405,-0.0672521105336032,0.011113637336654,-0.089034839713445,-0.0454693813537614,1.45494937845315e-09
PLA2G1B,Phospholipase A2,Physical measures,X21002.Weight,52413,-0.0528677668846919,0.00686143703722144,-0.0663161834776459,-0.0394193502917378,1.35107569433057e-14
PLA2G1B,Phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33670,-0.0156608320681149,0.00480916560125634,-0.0250867966465773,-0.00623486748965246,0.00113220451993211
PLA2G1B,Phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34555,-0.0144682581696981,0.040157533534525,-0.0931770238973672,0.0642405075579709,0.718639666457027
PLA2G1B,Phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34570,0.0443561061949911,0.0416712228833818,-0.0373194906564372,0.126031703046419,0.28715928843142
PLA2G1B,Phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34571,0.0692470845658566,0.0418704045440469,-0.0128189083404753,0.151313077472189,0.0981903990069245
PLA2G1B,Phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,34523,-0.0906974920842223,0.0386820044703053,-0.166514220846021,-0.014880763322424,0.0190619974653472
PLA2G1B,Phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34504,-0.0551911255306589,0.0407816804676038,-0.135123219247162,0.0247409681858446,0.175980266521803
PLA2G1B,Phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,34516,-0.0184662872977458,0.04180666552904,-0.100407351734664,0.0634747771391726,0.658710899462485
PLA2G1B,Phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,34422,0.0187346309673358,0.0415727913756352,-0.0627480401289091,0.100217302063581,0.652254181698628
PLA2G1B,Phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,34477,-0.0770423204367784,0.0475550344645947,-0.170250187987384,0.0161655471138273,0.105249460541467
PLA2G1B,Phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34574,0.0100192986694994,0.0419316479339805,-0.0721667312811025,0.0922053286201012,0.811154159093645
PLA2G1B,Phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34568,0.0830117384595419,0.0425510958835444,-0.000388409472205073,0.166411886391289,0.0510998563193162
PLA2G1B,Phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34571,0.0078674694111804,0.04930035186709,-0.088761220248316,0.104496159070677,0.873213214702347
PLA2G1B,Phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34571,-0.0559198867071904,0.043973739406506,-0.142108415943942,0.0302686425295615,0.203521227574859
PLA2G1B,Phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34568,0.0833879453042997,0.0650535262373188,-0.0441169661208452,0.210892856729445,0.199929598148726
PLA2G1B,Phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34569,-0.0136846255184952,0.0482164146697689,-0.108188798271242,0.0808195472342519,0.776556635291876
PLA2G1B,Phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34569,-0.133166198298647,0.122208313860826,-0.372694493465866,0.106362096868572,0.275886421279332
PLA2G1B,Phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34573,0.0703039267875061,0.0456510163184833,-0.0191720651967212,0.159779918771733,0.123584348285035
PLA2G1B,Phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34572,0.0569550276258963,0.0480941515574774,-0.0373095094267595,0.151219564678552,0.236345808951537
PLA2G1B,Phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34305,0.00303404467061172,0.0432982166105411,-0.0818304598860488,0.0878985492272723,0.944136818466792
PLA2G1B,Phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34569,0.0527411359940982,0.0434644614188842,-0.0324492083869149,0.137931480375111,0.224993313676209
PLA2G1B,Phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34571,-0.132158231518862,0.0569468528426261,-0.243774063090409,-0.0205423999473146,0.0203212348151971
PLA2G1B,Phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34573,0.0671157237080886,0.0420337720208141,-0.015270469452707,0.149501916868884,0.11036169663866
PLA2G1B,Phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34571,0.035298963182216,0.0420244838655686,-0.0470690251942984,0.11766695155873,0.400949624342102
PLA2G1B,Phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52267,0.0108466658615819,0.0240065850085021,-0.0362062407550822,0.057899572478246,0.651401864854859
PLA2G1B,Phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,48570,0.00568796071959287,0.00347318817028122,-0.00111948809415832,0.0124954095333441,0.101502116288894
PLA2G1B,Phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,47023,-0.0630644236484545,0.0273166502043759,-0.116605058049031,-0.00952378924787767,0.0209723281554188
PLA2G1B,Phospholipase A2,Physical activities,X22032.IPAQ activity group,46082,0.0192269611504488,0.027371919515121,-0.0344220010991883,0.0728759234000859,0.482416238544919
PLA2G1B,Phospholipase A2,Physical activities,X22033.Summed days activity,46774,0.000498166775784561,0.00329819916968038,-0.00596630359678898,0.0069626371483581,0.879943907291252
PLA2G1B,Phospholipase A2,Physical activities,X22034.Summed minutes activity,46082,0.00033432736023116,0.00331635145435235,-0.00616572149029944,0.00683437621076176,0.91970079372175
PLA2G1B,Phospholipase A2,Physical activities,X22037.MET minutes per week for walking,45029,0.000478331399389847,0.00336419684563822,-0.00611549441806105,0.00707215721684075,0.886936898539699
PLA2G1B,Phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,46082,-0.00318683090050588,0.00327516514040323,-0.00960615457569621,0.00323249277468444,0.330549733930663
PLA2G1B,Phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,46082,0.0313478357253082,0.0274828670729352,-0.0225185837376447,0.0852142551882612,0.254035753487241
PLA2G1B,Phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,45029,0.000227722203719916,0.00342412525966469,-0.00648356330522289,0.00693900771266272,0.94697624806059
PLA2G1B,Phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,48577,-0.00417468916143682,0.00316883794845432,-0.0103856115404073,0.00203623321753365,0.187710532431876
PLA2G1B,Phospholipase A2,Working and living environment,X22501.Year ended full time education,31429,0.0296267353890483,0.0142731069009574,0.00165144586317188,0.0576020249149247,0.0379579417440287
PLA2G1B,Phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,31385,0.115514178642315,0.10570326453998,-0.0916642198560451,0.322692577140675,0.274512743326669
PLA2G1B,Phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50594,-0.196835535530813,0.0570599739159117,-0.308673084406,-0.0849979866556265,0.000562250244504816
PLA2G1B,Phospholipase A2,Physical measures,X23098.Weight,51985,-0.0531839952614372,0.00691117701582084,-0.0667299022124461,-0.0396380883104284,1.45810183030411e-14
PLA2G1B,Phospholipase A2,Physical measures,X23099.Body fat percentage,51986,-0.0296152140211783,0.00710335091114266,-0.0435377818070179,-0.0156926462353387,3.0661937512742e-05
PLA2G1B,Phospholipase A2,Physical measures,X23100.Whole body fat mass,51978,-0.0502020479418352,0.00680065515156995,-0.0635313320389123,-0.0368727638447581,1.60412144379266e-13
PLA2G1B,Phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51985,-0.028593348690194,0.00569434046382317,-0.0397542559992874,-0.0174324413811006,5.16262920540925e-07
PLA2G1B,Phospholipase A2,Physical measures,X23102.Whole body water mass,51985,-0.029858015244737,0.00571365742350411,-0.0410567837948051,-0.018659246694669,1.74735130800109e-07
PLA2G1B,Phospholipase A2,Physical measures,X23104.Body mass index (BMI),51985,-0.0663798128432715,0.0112538560099748,-0.0884373706228221,-0.0443222550637209,3.71314129970828e-09
PLA2G1B,Phospholipase A2,Physical measures,X23105.Basal metabolic rate,51983,-0.0363983063636693,0.00620672253323764,-0.0485634825288151,-0.0242331301985235,4.56079717416462e-09
PLA2G1B,Phospholipase A2,Physical measures,X23106.Impedance of whole body,51979,0.000826996428255896,0.00465605453813907,-0.00829887046649667,0.00995286332300847,0.859024744097751
PLA2G1B,Phospholipase A2,Physical measures,X23107.Impedance of leg (right),51982,0.00418741492757244,0.00381115433149381,-0.00328244756215542,0.0116572774173003,0.271897141172508
PLA2G1B,Phospholipase A2,Physical measures,X23108.Impedance of leg (left),51981,0.00374525552242383,0.00377377640561432,-0.00365134623258024,0.0111418572774279,0.320990511885386
PLA2G1B,Phospholipase A2,Physical measures,X23109.Impedance of arm (right),51972,-0.00258340187774507,0.00466609572220355,-0.011728949493264,0.00656214573777388,0.579820260441652
PLA2G1B,Phospholipase A2,Physical measures,X23110.Impedance of arm (left),51980,0.000197412299302431,0.00468174673225216,-0.00897881129591179,0.00937363589451666,0.966366371521276
PLA2G1B,Phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51981,0.00333692873693953,0.0112130743536223,-0.0186406969961602,0.0253145544700393,0.766016315256334
PLA2G1B,Phospholipase A2,Physical measures,X23112.Leg fat mass (right),51980,-0.0920791712204387,0.0128809241768088,-0.117325782606984,-0.0668325598338935,8.99225255833149e-13
PLA2G1B,Phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51980,-0.031100115838992,0.00578192598358463,-0.0424326907668179,-0.0197675409111661,7.55736755576872e-08
PLA2G1B,Phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51979,-0.0320019511661333,0.00580374713253523,-0.0433772955459023,-0.0206266067863642,3.53885469486718e-08
PLA2G1B,Phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51976,0.00306197902388887,0.0115691138434433,-0.0196134841092599,0.0257374421570377,0.791266892998074
PLA2G1B,Phospholipase A2,Physical measures,X23116.Leg fat mass (left),51976,-0.0928515790935692,0.0129238275261247,-0.118182281044774,-0.0675208771423648,6.91547024096336e-13
PLA2G1B,Phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51974,-0.0331180847121656,0.00593053979751606,-0.0447419427152971,-0.0214942267090341,2.36816749959868e-08
PLA2G1B,Phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51973,-0.0325617629826114,0.00595352615719513,-0.0442306742507139,-0.020892851714509,4.55684054663262e-08
PLA2G1B,Phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51973,-0.0308072621141594,0.00790733416979876,-0.046305637086965,-0.0153088871413539,9.80109152486545e-05
PLA2G1B,Phospholipase A2,Physical measures,X23120.Arm fat mass (right),51970,-0.0524202536099188,0.00710368326764934,-0.0663434728145115,-0.0384970344053261,1.63615859238618e-13
PLA2G1B,Phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51971,-0.0252594707404025,0.00554185836200114,-0.0361215131299247,-0.0143974283508802,5.18792895735226e-06
PLA2G1B,Phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51970,-0.0244646159552484,0.00554115481744125,-0.0353252793974333,-0.0136039525130636,1.01359059228611e-05
PLA2G1B,Phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51967,-0.0327230956197351,0.00887167363090875,-0.0501115759363163,-0.015334615303154,0.000226021443823608
PLA2G1B,Phospholipase A2,Physical measures,X23124.Arm fat mass (left),51966,-0.0539819837913478,0.00728835000154201,-0.0682671497943701,-0.0396968177883254,1.3328494829703e-13
PLA2G1B,Phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51966,-0.0363608962463744,0.00596948598664569,-0.0480610887802,-0.0246607037125489,1.13604226599474e-09
PLA2G1B,Phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51964,-0.0316651564626788,0.00597727345291885,-0.0433806124303997,-0.0199497004949578,1.18241410474436e-07
PLA2G1B,Phospholipase A2,Physical measures,X23127.Trunk fat percentage,51962,-0.0235388105599378,0.00448516739625814,-0.0323297386566038,-0.0147478824632718,1.54776505494403e-07
PLA2G1B,Phospholipase A2,Physical measures,X23128.Trunk fat mass,51958,-0.0347250731274486,0.00516566776175194,-0.0448497819404824,-0.0246003643144148,1.82396777993274e-11
PLA2G1B,Phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51952,-0.0216571491354559,0.00531829153536576,-0.0320810005447728,-0.011233297726139,4.6701388400505e-05
PLA2G1B,Phospholipase A2,Physical measures,X23130.Trunk predicted mass,51949,-0.0219775651277315,0.00532699647091226,-0.0324184782107195,-0.0115366520447434,3.70703044762169e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,40514,-0.00711990116022151,0.00396336716027864,-0.0148881007943676,0.000648298473924616,0.0724453608945887
PLA2G1B,Phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40514,-0.00114208317250514,0.00383478872908826,-0.00865826908151813,0.00637410273650786,0.765843128496678
PLA2G1B,Phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40514,-0.0020305346226186,0.00382870030581729,-0.00953478722202048,0.00547371797678328,0.595879620219098
PLA2G1B,Phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,40514,0.00100953295411597,0.00375528488456602,-0.00635082541963344,0.00836989132786537,0.78806401663242
PLA2G1B,Phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40514,0.00212917125329111,0.00383828496063359,-0.00539386726955074,0.00965220977613295,0.579094306648969
PLA2G1B,Phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,40514,-0.000185527012730425,0.00383704552880138,-0.00770613624918113,0.00733508222372028,0.961436690635294
PLA2G1B,Phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,40514,-0.0191298559798543,0.00442042303782479,-0.0277938851339908,-0.0104658268257177,1.51648980941458e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,40514,-0.0203350972454588,0.00406119502558896,-0.0282950394956131,-0.0123751549953044,5.58212679526427e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,40514,-0.0168741076154332,0.0040641779241581,-0.0248398963467831,-0.00890831888408333,3.31411204112387e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,40514,-0.0214631711507108,0.00404078671391023,-0.0293831131099748,-0.0135432291914468,1.10096063110982e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,40514,-0.0296272929423358,0.00382629642000835,-0.0371268339255522,-0.0221277519591194,1.02802064350565e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40514,-0.0266604764400719,0.00403297475415173,-0.0345651069582093,-0.0187558459219345,3.94761380946259e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,40514,-0.0057225660539012,0.00386615543101751,-0.0133002306986955,0.00185509859089312,0.138847582616052
PLA2G1B,Phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,40514,-0.000541375711815401,0.00380817088723544,-0.00800539065079687,0.00692263922716607,0.8869541360477
PLA2G1B,Phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,40514,-0.036537724082881,0.00428308705514265,-0.0449325747109606,-0.0281428734548015,1.58281409054527e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,40514,-0.00799776866920732,0.00397628251036632,-0.0157912823895253,-0.00020425494888933,0.0443032398418718
PLA2G1B,Phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40514,0.00408004968971265,0.00373311881552111,-0.00323686318870873,0.011396962568134,0.274439498544687
PLA2G1B,Phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40514,-0.00165378905354954,0.00382925185406587,-0.00915912268751864,0.00585154458041956,0.6658321959242
PLA2G1B,Phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40514,-0.01719384006544,0.00439066055378464,-0.0257995347508579,-0.00858814538002211,9.04012496618482e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,40514,-0.00480923471220922,0.00392916719703743,-0.0125104024184026,0.00289193299398414,0.220976511660383
PLA2G1B,Phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40514,-0.00307975718678959,0.00382164734014518,-0.0105701859734741,0.00441067159989496,0.420328798852013
PLA2G1B,Phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,40514,0.00408491960182725,0.00386917786441255,-0.00349866901242136,0.0116685082160759,0.29109418421541
PLA2G1B,Phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,40514,-0.0245290920978996,0.00443797689376546,-0.0332275268096799,-0.0158306573861193,3.30655952339517e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40514,-0.0188046633908154,0.00394379174899667,-0.0265344952188489,-0.0110748315627819,1.87539069668557e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,40514,-0.00990667499975042,0.00394417384853592,-0.0176372557428808,-0.00217609425662001,0.012024038989914
PLA2G1B,Phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,40514,-0.00163190596406258,0.00382868355175201,-0.00913612572549652,0.00587231379737137,0.669944796165822
PLA2G1B,Phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,40514,-0.030656185591175,0.0043368692513378,-0.0391564493237971,-0.0221559218585529,1.6278362869525e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40514,-0.03200486344021,0.004054380879491,-0.0399514499640124,-0.0240582769164076,3.11692625957817e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,40514,-0.00237425554903249,0.00380894891461513,-0.00983979542167814,0.00509128432361317,0.533072498240999
PLA2G1B,Phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,40514,0.00768134981108064,0.00379815806724824,0.000236959999274095,0.0151257396228872,0.0431528099140759
PLA2G1B,Phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,40514,-0.0340385406049612,0.00406196022981449,-0.0419999826553976,-0.0260770985545248,5.73433446909411e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40514,-0.0126372786109842,0.00428952675292921,-0.0210447510467255,-0.00422980617524296,0.00322293654728941
PLA2G1B,Phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40514,0.0129435614704915,0.00391893619430436,0.00526244652965492,0.020624676411328,0.000959250984594237
PLA2G1B,Phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40514,0.00419982588890237,0.00464351704588499,-0.00490146752103221,0.0133011192988369,0.365770755106534
PLA2G1B,Phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,40499,-0.0357096282044292,0.00405026475285376,-0.0436481471200226,-0.0277711092888359,1.2988833867582e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40499,-0.00691959349121118,0.00430301197652252,-0.0153534969651953,0.00151430998277296,0.107837026681036
PLA2G1B,Phospholipase A2,NMR metabolomics,X23436.Total Cholines,40499,-0.0294887059413586,0.00406237826131071,-0.0374509673335276,-0.0215264445491896,4.07897477393538e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,40499,-0.0356780384697413,0.00406158109216382,-0.0436387374103824,-0.0277173395291002,1.7303679802396e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,40498,-0.0113604231809471,0.00409207340782449,-0.0193808870602831,-0.00333995930161107,0.00550617240866956
PLA2G1B,Phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,40514,0.0052432302377916,0.00379673261119217,-0.00219836568014505,0.0126848261557282,0.167302830312302
PLA2G1B,Phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,40514,-0.0345074961542776,0.0042006757776657,-0.0427408206785024,-0.0262741716300529,2.28655805058859e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40514,0.021311353964847,0.00382977587810493,0.0138049932437613,0.0288177146859327,2.66880598458637e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,40499,-0.027585927454361,0.00406113292583206,-0.0355457479889919,-0.0196261069197302,1.13945493032418e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,40499,0.025649471740665,0.00426402106900604,0.0172919904454132,0.0340069530359169,1.83424406535767e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40499,-0.0183716957621966,0.00398478595291228,-0.0261818762299047,-0.0105615152944885,4.04878185510715e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40499,-0.00517411673163272,0.00393103775836685,-0.0128789507380318,0.00253071727476632,0.188118482725686
PLA2G1B,Phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40499,-0.00891743508916049,0.00396463820578875,-0.0166881259725064,-0.00114674420581454,0.0245105362779359
PLA2G1B,Phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40499,-0.0247765771555633,0.00417092506994982,-0.0329515902926649,-0.0166015640184616,2.903675867996e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,40499,-0.0431575728096716,0.00413980139648177,-0.0512715835467759,-0.0350435620725673,2.29677065842446e-25
PLA2G1B,Phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,40499,0.00598953369793928,0.00389219305695532,-0.00163916469369315,0.0136182320895717,0.123858603573276
PLA2G1B,Phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,40499,-0.0093654438216313,0.00419308836470581,-0.0175838970164547,-0.00114699062680791,0.0255268742103859
PLA2G1B,Phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40499,-0.00612899014232399,0.00398520518447525,-0.0139399923038955,0.00168201201924749,0.124084003677304
PLA2G1B,Phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40499,0.0561201062040666,0.00442634866367668,0.0474444628232603,0.0647957495848728,1.16423609908192e-36
PLA2G1B,Phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40499,0.0536288355638324,0.00444958258634954,0.0449076536945873,0.0623500174330775,2.61877499837198e-33
PLA2G1B,Phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40499,-0.0113416176070662,0.00440214300213644,-0.0199698178912536,-0.00271341732287876,0.0099927798637635
PLA2G1B,Phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40499,-0.0733199350592898,0.00411315642284905,-0.0813817216480739,-0.0652581484705056,2.12925066940334e-70
PLA2G1B,Phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40499,0.0634962766746039,0.00424961402098215,0.0551670331934789,0.0718255201557289,3.83658513494562e-50
PLA2G1B,Phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40499,0.00884537374169264,0.00424975968331557,0.00051584476239412,0.0171749027209912,0.0374147596978294
PLA2G1B,Phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40499,0.0302926456491114,0.00444407993321834,0.0215822489800034,0.0390030423182193,9.66724226418735e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40497,0.0176710546310601,0.00396465461068251,0.00990033159412242,0.0254417776679978,8.36197350774514e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23460.Alanine,40507,-0.0193100164635234,0.00379616868385533,-0.0267505070838799,-0.011869525843167,3.68430616459923e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23461.Glutamine,40465,-0.00266018227710813,0.00383139229475122,-0.0101697111748205,0.00484934662060426,0.487496536666439
PLA2G1B,Phospholipase A2,NMR metabolomics,X23462.Glycine,40493,0.0311593451329199,0.00365670756740565,0.0239921983008048,0.0383264919650349,1.71851871852556e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23463.Histidine,40493,0.00377492495611628,0.00374305650003472,-0.00356146578395178,0.0111113156961843,0.313222972967285
PLA2G1B,Phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40503,-0.0210910052411116,0.00382127628310774,-0.0285807067560028,-0.0136013037262204,3.4550396599564e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23465.Isoleucine,40510,-0.0208555107166949,0.00374933999250421,-0.0282042171020032,-0.0135068043313867,2.7026148922644e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23466.Leucine,40511,-0.017364671390261,0.00382130358646739,-0.024854426419737,-0.00987491636078488,5.55529439281114e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23467.Valine,40503,-0.0220801718129622,0.00385250535665763,-0.0296310823120112,-0.0145292613139133,1.01405232162319e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23468.Phenylalanine,40510,0.000644166364331498,0.00373323854631896,-0.00667298118645365,0.00796131391511665,0.863008162102806
PLA2G1B,Phospholipase A2,NMR metabolomics,X23469.Tyrosine,40494,-0.0279327402401385,0.00375120386967539,-0.0352850998247023,-0.0205803806555747,1.00836402865027e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23470.Glucose,40480,-0.0422407818540383,0.00395232930689083,-0.0499873472955444,-0.0344942164125323,1.43019560162173e-26
PLA2G1B,Phospholipase A2,NMR metabolomics,X23471.Lactate,40480,-0.00939799930427532,0.00372002277442689,-0.016689243942152,-0.00210675466639861,0.0115357136949047
PLA2G1B,Phospholipase A2,NMR metabolomics,X23472.Pyruvate,40466,-0.0177518571142782,0.00384706380364157,-0.0252921021694157,-0.0102116120591407,3.97306571469576e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23473.Citrate,40512,0.0183809125030542,0.00381590780760859,0.0109017332001413,0.025860091805967,1.47123285776987e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,40311,-0.00568367805675625,0.00359447579360108,-0.0127288506122144,0.00136149449870187,0.113846347871212
PLA2G1B,Phospholipase A2,NMR metabolomics,X23475.Acetate,40500,0.00930514693235843,0.00387384888084003,0.00171240312591198,0.0168978907388049,0.0163151373742784
PLA2G1B,Phospholipase A2,NMR metabolomics,X23476.Acetoacetate,40513,-0.0222398786668715,0.00372252487720593,-0.0295360274261951,-0.0149437299075478,2.35805596233938e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23477.Acetone,40513,-0.0160531976764344,0.00373557329559059,-0.0233749213357919,-0.00873147401707681,1.7384184425583e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23478.Creatinine,40027,0.109707112181635,0.00431535820437118,0.101249010101068,0.118165214262203,9.90323267418817e-140
PLA2G1B,Phospholipase A2,NMR metabolomics,X23479.Albumin,40512,-0.00799007289246027,0.00386540850436193,-0.0155662735610097,-0.000413872223910884,0.0387434723492499
PLA2G1B,Phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,40514,0.00605866118140757,0.00411328508987882,-0.00200337759475493,0.0141206999575701,0.140784250595568
PLA2G1B,Phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40514,-0.0204085850802192,0.0041021104040113,-0.0284487214720813,-0.012368448688357,6.58735489861435e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40514,-0.0205204671897027,0.00410273993213942,-0.028561837456696,-0.0124790969227095,5.74416740083266e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40514,-0.0197948634187228,0.00403890811627426,-0.0277111233266204,-0.0118786035108253,9.62589213084835e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40514,-0.0181509542650669,0.00403420763060657,-0.0260580012210557,-0.010243907309078,6.86684297127137e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40514,-0.0172444067591693,0.00400969076632894,-0.0251034006611741,-0.00938541285716461,1.71277950526008e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40514,-0.0200893419838741,0.00405443482467319,-0.0280360342402336,-0.0121426497275146,7.31017574793917e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40514,-0.0239809540201758,0.00413043932904891,-0.0320766151051117,-0.0158852929352399,6.52259816128629e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40514,-0.0147874289293484,0.00402598095853682,-0.0226783516080805,-0.00689650625061619,0.000240497581539794
PLA2G1B,Phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40514,-0.0144649711723791,0.00403574044886652,-0.0223750224521575,-0.00655491989260072,0.00033909183948296
PLA2G1B,Phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40514,-0.012877525562872,0.0040000539053147,-0.0207176312172888,-0.00503741990845522,0.00128742258442212
PLA2G1B,Phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40514,-0.00601903256254154,0.00388912548076257,-0.0136417185048362,0.0016036533797531,0.121724583773927
PLA2G1B,Phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40514,-0.0017789384559502,0.00381042573853762,-0.00924737290348394,0.00568949599158354,0.640605796216206
PLA2G1B,Phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40514,-0.0105496652228362,0.00397262849072568,-0.0183360170646585,-0.00276331338101382,0.00792483774583408
PLA2G1B,Phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40514,-0.0196710193166765,0.00408135565254603,-0.0276704763956667,-0.0116715622376863,1.45069363688726e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40514,-0.011257905279934,0.00398950597438192,-0.0190773369897225,-0.0034384735701454,0.00478017283229083
PLA2G1B,Phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40514,-0.0114173680350955,0.00398185521635234,-0.019221804259146,-0.00361293181104488,0.00414464964209684
PLA2G1B,Phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40514,-0.0111057708129896,0.00396114683969602,-0.0188696186187938,-0.00334192300718539,0.00505843107633646
PLA2G1B,Phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40514,-0.00322884303656346,0.00384960948795122,-0.0107740776329478,0.00431639155982093,0.401624563096255
PLA2G1B,Phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40514,0.00251987549633446,0.00375809747571745,-0.00484599555607174,0.00988574654874066,0.502536684124863
PLA2G1B,Phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40514,-0.00900805391320905,0.00394769871084162,-0.0167455433864586,-0.00127056443995947,0.02251125382192
PLA2G1B,Phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40514,-0.0166652885911717,0.00404183456365881,-0.024587284335943,-0.00874329284640044,3.75524610827909e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40514,0.00270008438869449,0.00378628003315929,-0.00472102447629771,0.0101211932536867,0.475779843020891
PLA2G1B,Phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40514,-0.00123942998929387,0.00382574469308466,-0.0087378895877398,0.00625902960915207,0.745964276311997
PLA2G1B,Phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40514,0.00284041837710871,0.00377662542261548,-0.00456176745121763,0.0102426042054351,0.451999015735873
PLA2G1B,Phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40514,0.0137431822627274,0.00380349815243467,0.0062883258839555,0.0211980386414994,0.000303246867682923
PLA2G1B,Phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40514,0.0192342685330127,0.00386650444926911,0.0116559198124452,0.0268126172535801,6.60620246028872e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40514,0.00664119816438147,0.00376654043101743,-0.000741221080412692,0.0140236174091756,0.0778842501712195
PLA2G1B,Phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40514,-0.011803825706235,0.00396785599304851,-0.0195808234526101,-0.00402682795985993,0.00293555919185383
PLA2G1B,Phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40514,0.000335118493380455,0.00381267794408886,-0.00713773027703372,0.00780796726379463,0.929960566501958
PLA2G1B,Phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40514,-0.000531357130319452,0.00379191476092493,-0.00796351006173232,0.00690079580109342,0.88855984444058
PLA2G1B,Phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40514,0.00518850867224722,0.0037473418740174,-0.00215628140082689,0.0125332987453213,0.166199015782272
PLA2G1B,Phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40514,0.00728929948556431,0.00370560049022504,2.63225247232367e-05,0.0145522764464054,0.0491884714307708
PLA2G1B,Phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40514,0.00671494618450073,0.00368413389368784,-0.000505956247127433,0.0139358486161289,0.0683725505602442
PLA2G1B,Phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40514,0.00797398321465182,0.00375474499657067,0.0006146830213733,0.0153332834079303,0.0337097810484494
PLA2G1B,Phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40514,-0.0112389281022494,0.00393232685132676,-0.0189462887308498,-0.00353156747364895,0.00426752960042051
PLA2G1B,Phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40514,-0.000994411864061996,0.00383755648380377,-0.00851602257231738,0.00652719884419338,0.795541103570692
PLA2G1B,Phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40514,-0.00287931367411988,0.00383590367203335,-0.0103976848713052,0.00463905752306548,0.452891174881288
PLA2G1B,Phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40514,-0.000672294171397355,0.00382914857093959,-0.00817742537043895,0.00683283702764424,0.860631819871522
PLA2G1B,Phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40514,0.000916721187852285,0.00390518561300384,-0.00673744261363523,0.0085708849893398,0.814409970574852
PLA2G1B,Phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40514,0.000902192265538502,0.00393379596102755,-0.00680804781807549,0.0086124323491525,0.818604524288182
PLA2G1B,Phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40514,0.00105634445267565,0.00384661898966363,-0.00648302876706506,0.00859571767241636,0.783614538312892
PLA2G1B,Phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40514,-0.0139335478674662,0.00390327465826535,-0.0215839661976663,-0.00628312953726615,0.000358423013698412
PLA2G1B,Phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,40514,0.000349743440054109,0.0038492974109562,-0.00719487948542005,0.00789436636552826,0.927605735498835
PLA2G1B,Phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,40514,-0.00468773258535979,0.00395373083039249,-0.0124370450129291,0.00306157984220949,0.235778924352069
PLA2G1B,Phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,40514,0.000595586759084055,0.0039674868143183,-0.00718068739697982,0.00837186091514793,0.880674284096918
PLA2G1B,Phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,40514,-0.00402958987627233,0.00395818888386082,-0.0117876400886395,0.00372846033609489,0.308674849481243
PLA2G1B,Phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40514,-0.0063802762819444,0.00394824731766625,-0.0141188410245702,0.00135828846068144,0.106118957011872
PLA2G1B,Phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,40514,0.00292231073256988,0.00398159382520595,-0.00488161316483378,0.0107262346299735,0.462986872216582
PLA2G1B,Phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,40514,-0.0187010074813994,0.0039559739397266,-0.0264547164032636,-0.0109472985595353,2.29475064262076e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40514,0.0100512034345662,0.00381492412492356,0.00257395214971602,0.0175284547194164,0.0084290997408402
PLA2G1B,Phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,40514,-0.00166170490038884,0.00385900863063123,-0.00922536181642605,0.00590195201564837,0.666762044469883
PLA2G1B,Phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,40514,-0.00131656975276774,0.00384102522117006,-0.00884497918626105,0.00621183968072558,0.7317795984569
PLA2G1B,Phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,40514,0.000120178332691615,0.00387100985267173,-0.00746700097854497,0.0077073576439282,0.975233454469242
PLA2G1B,Phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40514,-0.000727744492728665,0.00385506874120157,-0.00828367922548374,0.00682819024002641,0.850270760542419
PLA2G1B,Phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40514,0.00248316764416322,0.00391131375320598,-0.0051830073121205,0.0101493426004469,0.525523601314787
PLA2G1B,Phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,40514,-0.0224081552409424,0.0040080076449297,-0.0302638502250046,-0.0145524602568802,2.29643705674194e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40514,0.00248288097467361,0.00379184913572887,-0.00494914333135498,0.00991490528070219,0.512609615761434
PLA2G1B,Phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40514,-0.00292325281256261,0.00380594768419708,-0.0103829102735889,0.00453640464846366,0.442453991100788
PLA2G1B,Phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40514,-0.00156600530129639,0.00377852126581571,-0.00897190698229519,0.0058398963797024,0.678550662092021
PLA2G1B,Phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40514,-0.00198424316836197,0.00380654693658116,-0.00944507516406104,0.00547658882733709,0.602185069587953
PLA2G1B,Phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40514,-0.00431567630852763,0.00381981534303407,-0.0118025143808744,0.00317116176381915,0.258571980771293
PLA2G1B,Phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40514,0.00468670276914045,0.00380857199932404,-0.00277809834953466,0.0121515038878156,0.218502899136284
PLA2G1B,Phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40514,-0.0195590006597783,0.00406782304635716,-0.0275319338306384,-0.0115860674889183,1.53657361768776e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40514,0.00613152611318278,0.0037771079057788,-0.00127160538214367,0.0135346576085092,0.104536606652537
PLA2G1B,Phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,40514,0.0024975894754241,0.00381016761372101,-0.00497033904746908,0.00996551799831729,0.512151118420299
PLA2G1B,Phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,40514,0.00592964764672679,0.00378939027150872,-0.0014975572854303,0.0133568525788839,0.117648908508703
PLA2G1B,Phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,40514,0.00309745057152018,0.00380133353969621,-0.0043531631662844,0.0105480643093247,0.415180206784986
PLA2G1B,Phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40514,-0.000154308499393262,0.00382570913970124,-0.0076526984132077,0.00734408141442117,0.967826859976563
PLA2G1B,Phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40514,0.0115618262446317,0.00378172249821238,0.00414965014813545,0.018974002341128,0.00223714384035562
PLA2G1B,Phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,40514,-0.0158262255601006,0.00410467783619806,-0.0238713941190488,-0.00778105700115235,0.000115869605437642
PLA2G1B,Phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40514,0.00888910274955592,0.00440622153542272,0.000252908540127383,0.0175252969589844,0.0436705906285051
PLA2G1B,Phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40514,0.0100667906856393,0.00443610618282983,0.00137202256729286,0.0187615588039858,0.0232641815039477
PLA2G1B,Phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40514,0.00934406995369045,0.00444020821044997,0.000641261861208503,0.0180468780461724,0.0353571866856733
PLA2G1B,Phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40514,0.0128276014653029,0.00440564204142145,0.00419254306411686,0.021462659866489,0.00360042269259121
PLA2G1B,Phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40514,0.0131638974404889,0.00447686695030707,0.00438923821788708,0.0219385566630908,0.00328228158763406
PLA2G1B,Phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40514,0.0106216489045486,0.00410520803265916,0.00257544116053666,0.0186678566485606,0.00968016350650846
PLA2G1B,Phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40514,-0.0123589884687985,0.00397126779164075,-0.0201426733404144,-0.00457530359718266,0.00186086467439001
PLA2G1B,Phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40514,-0.0023751891536934,0.0046679138523428,-0.0115243003042853,0.00677392199689848,0.610876193595367
PLA2G1B,Phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,40514,-0.00663118875769768,0.00464426816421138,-0.015733954359552,0.00247157684415663,0.153362509890698
PLA2G1B,Phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,40514,-0.0129681335462651,0.00458446726621199,-0.0219536893880406,-0.0039825777044896,0.00467937523336058
PLA2G1B,Phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,40514,0.00178520141836467,0.00464257163836417,-0.00731423899282909,0.0108846418295584,0.700591817915295
PLA2G1B,Phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40514,0.00381965792777826,0.00462956685351172,-0.0052542931051047,0.0128936089606612,0.409351313287609
PLA2G1B,Phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40514,-0.00506532080071696,0.00463673464719518,-0.0141533207092195,0.0040226791077856,0.274659317611766
PLA2G1B,Phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,40514,-0.0227299559989688,0.00392582343894722,-0.0304245699393053,-0.0150353420586322,7.17615448884513e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40514,-0.0365911787020996,0.00416523049252938,-0.0447550304674572,-0.028427326936742,1.72047676359775e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40514,-0.0411437681169608,0.00412603247868455,-0.0492307917751825,-0.0330567444587391,2.36912494333713e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40514,-0.0456448409026684,0.004097647627558,-0.0536762302526821,-0.0376134515526547,1.02910742823758e-28
PLA2G1B,Phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40514,-0.0324054086878789,0.00418044484004014,-0.0405990805743576,-0.0242117368014002,9.61026308309427e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40514,-0.031371751425195,0.00415967458850125,-0.0395247136186575,-0.0232187892317326,4.87979704607812e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40514,-0.0355214958218246,0.00423279622375597,-0.0438177764203863,-0.0272252152232629,5.17439906244349e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40514,-0.0340143203674006,0.00379042668086739,-0.0414435566619007,-0.0265850840729005,3.17722194058194e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40514,-0.0332352316215289,0.00374781039365627,-0.0405809399930952,-0.0258895232499626,8.2238629739215e-19
PLA2G1B,Phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,40514,-0.0444839660680677,0.00378190486293331,-0.051896499599417,-0.0370714325367184,8.24307675913794e-32
PLA2G1B,Phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,40514,-0.0497431015113443,0.00381862239360042,-0.0572276014028012,-0.0422586016198875,1.35758192641729e-38
PLA2G1B,Phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,40514,-0.0327613413958799,0.00375559302798317,-0.0401223037307269,-0.0254003790610329,2.96182770969193e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40514,-0.0293945666559977,0.00371547941478491,-0.0366769063089761,-0.0221122270030193,2.7103713508697e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40514,-0.0382309015942459,0.0038902912906077,-0.045855872523837,-0.0306059306646548,9.95887595884962e-23
PLA2G1B,Phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,40514,-0.0259025992750032,0.00391447928267006,-0.0335749786690365,-0.0182302198809699,3.77834141698352e-11
PLA2G1B,Phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39633,0.00787537721733545,0.00356303623919393,0.000891826188515353,0.0148589282461555,0.0270992421191513
PLA2G1B,Phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39633,0.0182498390560175,0.0037387180337968,0.0109219517097758,0.0255777264022592,1.06454807059504e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39633,0.0151669356740841,0.00364570874286603,0.00802134653806668,0.0223125248101015,3.19696419354714e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39633,0.0204468868583638,0.00380991986478262,0.0129794439233899,0.0279143297933378,8.1345428897798e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39633,-0.0164167309965087,0.00362454643534842,-0.0235208420097916,-0.00931261998322577,5.96245031203739e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40277,0.0192672618801752,0.00349694996471987,0.0124132399493242,0.0261212838110261,3.6498620667476e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40277,0.0323844318274301,0.00396891893083502,0.0246053507229934,0.0401635129318667,3.61469861301104e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40277,0.0307165372307768,0.00397933951780448,0.0229170317758801,0.0385160426856736,1.24219722650391e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40277,0.0313882610113121,0.00375972355786131,0.0240192028379039,0.0387573191847203,7.47611130845939e-17
PLA2G1B,Phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40277,-0.0330068740967325,0.00380636126473587,-0.0404673421756149,-0.0255464060178502,4.67266599668856e-18
PLA2G1B,Phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40509,0.00118036188886859,0.003742668872693,-0.00615526910160969,0.00851599287934687,0.752477455750623
PLA2G1B,Phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40509,0.0350547487472408,0.00368793445781949,0.0278263972099146,0.042283100284567,2.27134414456503e-21
PLA2G1B,Phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40509,0.039703411013245,0.00386963338505925,0.0321189295785289,0.0472878924479612,1.26789890046898e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40509,0.0194396312336779,0.00354971835061958,0.0124821832664635,0.0263970792008923,4.4061761908623e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40509,-0.0283148883655139,0.00348219878290954,-0.0351399979800166,-0.0214897787510112,4.55376756577379e-16
PLA2G1B,Phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40514,0.0223792475084067,0.00390155105798241,0.0147322074347612,0.0300262875820523,9.86906018969765e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40514,0.0299134706712392,0.00407862753818216,0.0219193606964021,0.0379075806460762,2.33688014522234e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40514,0.0298207449507245,0.00410916333135117,0.0217667848212762,0.0378747050801728,4.13455691959519e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40514,0.0280233915120513,0.00398836219088098,0.0202062016179245,0.035840581406178,2.2061535842372e-12
PLA2G1B,Phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40514,-0.0289818935586214,0.00404912027979364,-0.0369181693070169,-0.0210456178102258,8.56666554990415e-13
PLA2G1B,Phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40514,0.0234147256001379,0.00397384429613469,0.0156259907797139,0.0312034604205619,3.88684772993662e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40514,0.0237831705921502,0.00388837955887371,0.0161619466567577,0.0314043945275427,9.78849699155626e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40514,0.0238540486639079,0.00377926257350005,0.0164466940198478,0.031261403307968,2.8299403437596e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40514,0.019715636923983,0.00398795446819194,0.0118992461663268,0.0275320276816392,7.73883873942831e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40514,-0.0241431412035985,0.0039203814284514,-0.0318270888033632,-0.0164591936038337,7.52487208717027e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40514,0.0179013412903236,0.00398770004107984,0.0100854492098071,0.0257172333708401,7.20089151345801e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40514,0.0128538296990668,0.00414448463557812,0.00473063981333366,0.0209770195847999,0.00192921882742006
PLA2G1B,Phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40514,0.00943805252100915,0.00417088938386134,0.00126310932864093,0.0176129957133774,0.023658889928523
PLA2G1B,Phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40514,0.030695623930845,0.00404299189264978,0.0227713598212515,0.0386198880404386,3.31494858821694e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40514,-0.0191356716501293,0.00413689041927893,-0.027243976871916,-0.0110273664283426,3.76399094245873e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40514,0.0295544862189195,0.0037181428054887,0.0222669263201616,0.0368420461176773,2.00883110383204e-15
PLA2G1B,Phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40514,-0.00134518780129312,0.00394109727282192,-0.00906973845602408,0.00637936285343785,0.73286477430091
PLA2G1B,Phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40514,-0.0150313522971446,0.00392497342360432,-0.0227243002074091,-0.00733840438688017,0.000128802849723982
PLA2G1B,Phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40514,0.0312216840682225,0.00404073896803951,0.0233018356908651,0.03914153244558,1.16841385474338e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40514,-0.0150245613740862,0.0040700021572788,-0.0230017656023526,-0.00704735714581973,0.00022364095134315
PLA2G1B,Phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40514,0.00229914219010279,0.00370833006554498,-0.00496918473836537,0.00956746911857095,0.535270568099425
PLA2G1B,Phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40514,0.0213630216160748,0.00407910404963234,0.0133679776787954,0.0293580655533542,1.65101414307312e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40514,0.00839073188897156,0.00376096686255565,0.00101923683836249,0.0157622269395806,0.0256946179155789
PLA2G1B,Phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40514,0.0136783074252624,0.0040751943098639,0.00569092657792914,0.0216656882725956,0.000791245476504921
PLA2G1B,Phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40514,-0.0232276070261408,0.00405608130716613,-0.0311775263881865,-0.0152776876640952,1.04287740450181e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40514,0.0095259333702676,0.00367501049178709,0.00232291280636491,0.0167289539341703,0.00954830390653092
PLA2G1B,Phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40514,0.0109792160934192,0.00378291502741387,0.00356470263968805,0.0183937295471504,0.00370917854326889
PLA2G1B,Phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40514,-0.0117249095426431,0.00383420405119285,-0.0192399494829811,-0.00420986960230508,0.00223202870107662
PLA2G1B,Phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40514,0.0230670174287626,0.00415102669428927,0.0149310051079556,0.0312030297495696,2.78904887586076e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40514,-0.0203428196854511,0.00391941157872405,-0.0280248663797502,-0.0126607729911519,2.12543048135038e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40514,0.0113072473686772,0.00374989063759066,0.00395746171899954,0.0186570330183549,0.00257080626647928
PLA2G1B,Phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40514,0.00696337685438523,0.00380193513530479,-0.000488416010812163,0.0144151697195826,0.0670392551740271
PLA2G1B,Phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40514,-0.0131281387262463,0.00378447202061733,-0.0205457038866563,-0.00571057356583633,0.000523869244870048
PLA2G1B,Phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40514,0.0245825958433165,0.00405778213533294,0.016629342858064,0.0325358488285691,1.40779808155067e-09
PLA2G1B,Phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40514,-0.0218922978342663,0.00401211277058581,-0.0297560388646145,-0.0140285568039181,4.92658466266232e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40512,0.00203387238851384,0.00432059476156888,-0.00643449334416116,0.0105022381211888,0.637833534873915
PLA2G1B,Phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40512,0.0103090714191109,0.00430949173055419,0.00186246762722473,0.0187556752109972,0.0167601418729903
PLA2G1B,Phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40512,0.0157850952301734,0.00431921850667507,0.0073194269570903,0.0242507635032566,0.000258385566088697
PLA2G1B,Phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40512,-0.00261138383835564,0.00458643129974009,-0.0116007891858462,0.00637802150913494,0.569111932465468
PLA2G1B,Phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40512,-0.0170622600277657,0.00430353424287046,-0.0254971871437918,-0.00862733291173955,7.38039482430533e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40514,-0.0580421528380718,0.00446266430395984,-0.0667889748738331,-0.0492953308023105,1.7656564571929e-38
PLA2G1B,Phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40514,0.0426462125768333,0.00444711995882837,0.0339298574575297,0.0513625676961369,1.01079237566441e-21
PLA2G1B,Phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40514,0.0454970321196936,0.00449015690518132,0.0366963245855382,0.054297739653849,4.67662729427502e-24
PLA2G1B,Phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40514,0.00895957617207652,0.00432477743437988,0.000483012400691945,0.0174361399434611,0.0383107594062509
PLA2G1B,Phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40514,-0.0167222521491839,0.00432676702707666,-0.0252027155222541,-0.00824178877611361,0.000111600316930364
PLA2G1B,Phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40514,-0.0232150976610107,0.00422351420019538,-0.0314931854933936,-0.0149370098286277,3.93012917958458e-08
PLA2G1B,Phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40514,0.0177137663394094,0.00411832979736287,0.0096418399365782,0.0257856927422407,1.70877647230213e-05
PLA2G1B,Phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40514,0.0213275646006748,0.00409147695365323,0.0133082697715144,0.0293468594298351,1.88436500912691e-07
PLA2G1B,Phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40514,-0.00680629466594639,0.00442997634501088,-0.0154890483021677,0.00187645897027494,0.124455632529415
PLA2G1B,Phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40514,-0.0133488201284007,0.00400940659223342,-0.0212072570491782,-0.00549038320762321,0.000872368287150609
PLA2G1B,Phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40514,-0.036921679492676,0.00391583917691024,-0.0445967242794201,-0.0292466347059319,4.70167155289162e-21
PLA2G1B,Phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40514,0.0302868551395221,0.00392489369280743,0.0225940635016196,0.0379796467774247,1.26462418400378e-14
PLA2G1B,Phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40514,0.0247007165987409,0.00393932094040332,0.0169796475555504,0.0324217856419314,3.69565084193819e-10
PLA2G1B,Phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40514,0.0181417812903779,0.0040059455188077,0.0102901280735149,0.025993434507241,5.977069992005e-06
PLA2G1B,Phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40514,-0.007752812149304,0.00400608870760045,-0.0156047460162009,9.91217175928911e-05,0.0529762690931158
PLA2G1B,Phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52107,0.00315558455238705,0.00325887513879232,-0.0032318107196459,0.00954297982442,0.332900618975425
PLA2G1B,Phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52107,0.000585491115884332,0.00319271660858161,-0.00567223343693563,0.00684321566870429,0.854498571562678
PLA2G1B,Phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50213,-0.00185431243481892,0.00305115431995126,-0.00783457490192339,0.00412595003228556,0.543364436627828
PLA2G1B,Phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50213,0.00303140949034058,0.00332074892325711,-0.00347725839924336,0.00954007737992453,0.361319868754073
PLA2G1B,Phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50213,-0.000265238250964365,0.00326214381310672,-0.00665904012465354,0.00612856362272481,0.935197677313123
PLA2G1B,Phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50213,-0.00167530848771555,0.00298811408389783,-0.0075320120921553,0.00418139511672419,0.575035940278595
PLA2G1B,Phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,52107,0.0162415237680289,0.0527996709391548,-0.0872458312727145,0.119728878808772,0.758384064317104
PLA2G1B,Phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,52107,-0.00296501780331286,0.00284665441191367,-0.00854446045066364,0.00261442484403793,0.297615631880892
PLA2G1B,Phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,52107,0.000524396071548569,0.00285299754266564,-0.00506747911207609,0.00611627125517323,0.854167545128334
PLA2G1B,Phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,52107,-0.00348486646611507,0.00290015739926529,-0.00916917496867503,0.00219944203644489,0.229523841347338
PLA2G1B,Phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,52107,-0.0745420355301735,0.0367078396621309,-0.14648940126795,-0.00259466979239691,0.042296572835093
PLA2G1B,Phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,52107,-0.0605954425476788,0.0355893389945577,-0.130350546977012,0.00915966188165425,0.0886487475759008
PLA2G1B,Phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52107,0.00320648160589323,0.00324130739291484,-0.00314648088421985,0.00955944409600632,0.322546738955235
PLA2G1B,Phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52107,0.00266232129352167,0.00323428508842617,-0.00367687747979362,0.00900152006683696,0.410426364029533
PLA2G1B,Phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52107,0.00275060588860757,0.00320353438567124,-0.00352832150730807,0.00902953328452321,0.390559847992267
PLA2G1B,Phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52040,0.00218533230703917,0.00315598039945748,-0.00400038927589748,0.00837105388997583,0.488665839278047
PLA2G1B,Phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,52107,-0.00338741037052211,0.00286822642030245,-0.00900913415431492,0.00223431341327069,0.237608036777831
PLA2G1B,Phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,52107,-0.00339082166936254,0.0028679571165306,-0.00901201761776252,0.00223037427903744,0.23709187601515
PLA2G1B,Phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,52107,-0.00338734517429875,0.00286818227831225,-0.00900898243979076,0.00223429209119325,0.237609846152406
PLA2G1B,Phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52107,-0.0034236329423845,0.00286795854485631,-0.00904483169030287,0.00219756580553387,0.232585001681904
PLA2G1B,Phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52107,-0.00342879325691015,0.00286794097546475,-0.00904995756882105,0.00219237105500075,0.231878867322322
PLA2G1B,Phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49125,-0.00403707133607233,0.00333468208286604,-0.0105730482184898,0.0024989055463451,0.22604824395712
PLA2G1B,Phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49125,0.00698561023157037,0.00303979922336344,0.00102760375377804,0.0129436167093627,0.0215672741474776
PLA2G1B,Phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",49125,-0.00163426306780167,0.00298071127464659,-0.00747645716610898,0.00420793103050564,0.583504920265255
PLA2G1B,Phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49125,-0.00247180405020577,0.0031431883536136,-0.00863245322328842,0.00368884512287688,0.431640600342567
PLA2G1B,Phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49125,0.00364713692440604,0.00306274114010542,-0.00235583571020057,0.00965010955901266,0.233740388677052
PLA2G1B,Phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",49125,-0.000893801063349854,0.00299564413761884,-0.00676526357308279,0.00497766144638308,0.765425659520449
PLA2G1B,Phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52267,-0.00445453654048357,0.00318933752731751,-0.0107056380940259,0.00179656501305875,0.16251600289034
PLA2G1B,Phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52267,-0.00545748834570177,0.00300714875272357,-0.01135149990104,0.000436523209636434,0.0695595485052616
PLA2G1B,Phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52267,0.00326192482248849,0.00287224723631228,-0.00236767976068358,0.00889152940566057,0.256104514446824
PLA2G1B,Phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35759,-0.0616649933290082,0.0384386718807005,-0.137004790215181,0.0136748035571647,0.108688299192101
PLA2G1B,Phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,45732,-0.0566914162712155,0.028624916870283,-0.11279625333697,-0.000586579205460791,0.0476611390360866
PLA2G1B,Phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),51600,-0.0267114362281165,0.0242736018680811,-0.0742876958895555,0.0208648234333225,0.271153915601863
PLA2G1B,Phospholipase A2,Health and medical history,X2734.Number of live births,52438,-0.0235549424176816,0.0233417419452781,-0.0693047566304267,0.0221948717950634,0.312919162752904
PLA2G1B,Phospholipase A2,Health and medical history,X2744.Birth weight of first child,46632,-0.0652620563092077,0.0261308465083412,-0.116478515465556,-0.014045597152859,0.0125140765973842
PLA2G1B,Phospholipase A2,Health and medical history,X2754.Age at first live birth,43347,0.00840212360798225,0.00359707897220834,0.0013518488224539,0.0154523983935106,0.019511107262521
PLA2G1B,Phospholipase A2,Health and medical history,X2764.Age at last live birth,43296,0.00606443185047774,0.0034676351710966,-0.000732133084871595,0.0128609967858271,0.0803303363288434
PLA2G1B,Phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,45922,0.00224572532941263,0.00391372588734977,-0.00542517740979291,0.00991662806861817,0.566104072833173
PLA2G1B,Phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,43922,0.00606105821634492,0.00337689586127354,-0.000557657671751225,0.0126797741044411,0.0726913759551805
PLA2G1B,Phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,30162,0.00600693206009393,0.00656076145181673,-0.00685216038546687,0.0188660245056547,0.359923482703761
PLA2G1B,Phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35699,0.05880016843776,0.0448934107069204,-0.029190916547804,0.146791253423324,0.190299463004739
PLA2G1B,Phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35692,0.106822630065682,0.0486810764605867,0.0114077202029323,0.202237539928432,0.0282316698912725
PLA2G1B,Phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35729,0.0622750338587572,0.0531276973995677,-0.0418552530443954,0.16640532076191,0.241151002110872
PLA2G1B,Phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35685,0.0185864993031338,0.0509141816066264,-0.081205296645854,0.118378295252122,0.715076891613834
PLA2G1B,Phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,35740,-0.114617042143111,0.0446476835239264,-0.202126501850007,-0.0271075824362152,0.0102667644477378
PLA2G1B,Phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,35769,-0.0200522228419407,0.0482935841197027,-0.114707647716558,0.0746032020326766,0.67799235751615
PLA2G1B,Phospholipase A2,Mental health,X28741.Difficulty learning a new task,35659,-0.0662243402336663,0.0539892024424728,-0.172043177020913,0.0395944965535804,0.219990495700937
PLA2G1B,Phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,35373,0.0762938570998115,0.0570222945637142,-0.0354698402450683,0.188057554444691,0.180935582234498
PLA2G1B,Phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35690,0.0372503130558753,0.0475566752514081,-0.0559607704368847,0.130461396548635,0.43347772882785
PLA2G1B,Phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35763,-0.0175086032560373,0.0702562300498183,-0.155210814153681,0.120193607641607,0.803202340491382
PLA2G1B,Phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,30134,0.0183797739250834,0.0535605482287406,-0.0865989006032482,0.123358448453415,0.731491688556295
PLA2G1B,Phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,30172,-0.00885550038150186,0.00674560609889274,-0.0220768883353316,0.00436588757232791,0.189309568535387
PLA2G1B,Phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34602,-0.00459739164426525,0.00910375857845419,-0.0224407584580355,0.013245975169505,0.613570296751076
PLA2G1B,Phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34602,0.00230655079158759,0.00969708940224152,-0.0166997444368058,0.021312846019981,0.811994393215851
PLA2G1B,Phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34602,0.00595329272459643,0.0325262045161356,-0.0577980681270294,0.0697046535762222,0.854777616360966
PLA2G1B,Phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34602,-0.0163907284807432,0.034229441243114,-0.0834804333172466,0.0506989763557602,0.632056478598344
PLA2G1B,Phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34602,-0.039034622035541,0.035723287658977,-0.109052265847136,0.0309830217760539,0.274554109340301
PLA2G1B,Phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34602,0.0713396866332891,0.0295134371330586,0.0134933498524942,0.129186023414084,0.0156582129190109
PLA2G1B,Phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34602,-0.0105217075297984,0.0137123050536217,-0.037397825434897,0.0163544103753002,0.442909925152604
PLA2G1B,Phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34602,-0.026079973068851,0.0241976950166373,-0.0735074553014601,0.0213475091637581,0.281154215627129
PLA2G1B,Phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34531,-0.172654680167079,0.0534818878323316,-0.277479180318449,-0.0678301800157093,0.00124934266956577
PLA2G1B,Phospholipase A2,Mental health,X29003.Recent feelings of depression,34514,-0.114750746738719,0.0510743878888577,-0.21485654700088,-0.0146449464765576,0.0246783985117746
PLA2G1B,Phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34533,-0.0458887100117233,0.0420882582783445,-0.128381696237279,0.036604276213832,0.275608314752531
PLA2G1B,Phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,34541,-0.0827802584839411,0.0428627831976307,-0.166791313551297,0.00123079658341517,0.0534757767969302
PLA2G1B,Phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,34547,-0.129500175531383,0.0547019808569439,-0.236716058010994,-0.0222842930517734,0.0179334572933848
PLA2G1B,Phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,34500,0.0206250521942004,0.0555259355032613,-0.0882057813921917,0.129455885780593,0.710310982250663
PLA2G1B,Phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,34547,-0.0291952327656445,0.0561807228625111,-0.139309449576166,0.0809189840448774,0.603307520922995
PLA2G1B,Phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34533,0.0248430245228446,0.0991796100609224,-0.169549011196563,0.219235060242252,0.802217253743737
PLA2G1B,Phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,34470,-0.122145153541349,0.111109142996404,-0.339919073814301,0.0956287667316024,0.271652381626668
PLA2G1B,Phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,33193,0.0540968946944432,0.0188026037852814,0.0172437912752917,0.0909499981135947,0.00402325198125843
PLA2G1B,Phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),33193,-0.0347421873557388,0.0378051805827948,-0.108840341298017,0.0393559665865389,0.358131633224647
PLA2G1B,Phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),33193,0.0402527149540971,0.017619745938204,0.00571801291521714,0.074787416992977,0.0223646685477571
PLA2G1B,Phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),33193,0.0397478126194657,0.0508452110130975,-0.0599088009662054,0.139404426205137,0.434387668211493
PLA2G1B,Phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),33193,-0.00190864299461374,0.0324255180042304,-0.0654626582829052,0.0616453722936778,0.953063072156528
PLA2G1B,Phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),33193,0.051434608906928,0.0338465343590617,-0.014904598436833,0.117773816250689,0.128637190789952
PLA2G1B,Phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),33193,0.0274724448259803,0.0386862647917719,-0.0483526341658926,0.103297523817853,0.477639781992515
PLA2G1B,Phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),33193,0.0319937297199658,0.0448258903549755,-0.0558650153757862,0.119852474815718,0.475411179957753
PLA2G1B,Phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),33193,0.0421493345659598,0.0341598717124504,-0.024804013990443,0.109102683122363,0.217279138822783
PLA2G1B,Phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,33193,0.0277570120001708,0.0189203261912803,-0.00932682733473856,0.0648408513350802,0.142399186146077
PLA2G1B,Phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,33193,-0.00202827688999195,0.0286907998991269,-0.0582622446922807,0.0542056909122968,0.943642650415591
PLA2G1B,Phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,33193,-0.00324596716399222,0.0443176632536364,-0.0901085871411196,0.0836166528131351,0.941614271468795
PLA2G1B,Phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,33193,-0.00883978523711126,0.0593228261253183,-0.125112524442735,0.107432953968513,0.881547970440946
PLA2G1B,Phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,33193,0.0150749204793031,0.0381033428741664,-0.059607631554063,0.0897574725126693,0.692385819356379
PLA2G1B,Phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,33193,-0.0413978914896297,0.064903195414095,-0.168608154501256,0.0858123715219966,0.52359417187796
PLA2G1B,Phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,33193,-0.0127640634461588,0.0621521320096926,-0.134582242185156,0.109054115292839,0.837289346614069
PLA2G1B,Phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,33193,0.0154342573885304,0.0326485845335062,-0.0485569682971417,0.0794254830742026,0.63641124164383
PLA2G1B,Phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,33193,-0.0112625592174213,0.0321084913164993,-0.07419520219776,0.0516700837629174,0.725772542832989
PLA2G1B,Phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,33193,0.0270666470317398,0.0443228681889757,-0.0598061746186526,0.113939468682132,0.541433931506222
PLA2G1B,Phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,34385,-0.0607037555775675,0.0474240422259526,-0.153654878340435,0.0322473671852996,0.200567756004098
PLA2G1B,Phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,34397,-0.0188223890047448,0.0485931254312304,-0.114064914849956,0.0764201368404667,0.698507813756317
PLA2G1B,Phospholipase A2,Mental health,X29060.Recent worrying too much about different things,34388,-0.00383276601688122,0.0457456858222056,-0.0934943102284043,0.0858287781946418,0.933229692947727
PLA2G1B,Phospholipase A2,Mental health,X29061.Recent trouble relaxing,34394,-0.0340089432806956,0.0483086132691396,-0.128693825288209,0.060675938726818,0.481453395926315
PLA2G1B,Phospholipase A2,Mental health,X29062.Recent restlessness,34407,0.0586117331050137,0.0705633509750863,-0.0796924348061555,0.196915901016183,0.406205033103865
PLA2G1B,Phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,34371,-0.0508484795391289,0.0508846479884653,-0.150582389596521,0.0488854305182631,0.317678993911288
PLA2G1B,Phospholipase A2,Mental health,X29064.Recent feelings of foreboding,34360,-0.0468922878174952,0.0548141128307917,-0.154327948965847,0.0605433733308565,0.392307065238742
PLA2G1B,Phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,33193,-0.0053178297086043,0.0184512170810435,-0.0414822151874496,0.030846555770241,0.77319264403126
PLA2G1B,Phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,33193,0.0489734457155549,0.0325104698886363,-0.0147470752661722,0.112693966697282,0.132003230047312
PLA2G1B,Phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',33193,-0.000330284852346606,0.0405060278486207,-0.0797220994356433,0.07906152973095,0.993494333044737
PLA2G1B,Phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,33193,0.0436191291192634,0.0444801972430502,-0.0435620574771149,0.130800315715642,0.32679668250087
PLA2G1B,Phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,33193,-0.0139502513437215,0.0302386640299234,-0.0732180328423713,0.0453175301549283,0.644567449609763
PLA2G1B,Phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,33193,0.0458568846808312,0.0299306522325582,-0.0128071936949829,0.104520963056645,0.125532857613678
PLA2G1B,Phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,33193,0.0130794849139164,0.0307239248599501,-0.0471394078115857,0.0732983776394185,0.670329587618957
PLA2G1B,Phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,33193,0.0067482482884205,0.0275242016806156,-0.0471991870055862,0.0606956835824272,0.806326628161133
PLA2G1B,Phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,33193,0.0128919584966695,0.0374919970616992,-0.060592355744261,0.0863762727376,0.73096064041094
PLA2G1B,Phospholipase A2,Mental health,X29076.Felt loved as a child,34361,0.0543137880292729,0.0449446590120305,-0.0337777436343068,0.142405319692853,0.226899514884346
PLA2G1B,Phospholipase A2,Mental health,X29077.Physically abused by family as a child,34375,-0.0868621163511766,0.0622468902238037,-0.208866021189832,0.0351417884874787,0.162912902336926
PLA2G1B,Phospholipase A2,Mental health,X29078.Felt hated by family member as a child,34354,-0.0217456014809443,0.0578131422605039,-0.135059360311532,0.0915681573496433,0.706823886090123
PLA2G1B,Phospholipase A2,Mental health,X29079.Sexually molested as a child,34246,-0.0349669912408299,0.0735352034967957,-0.179095990094549,0.10916200761289,0.634431531724393
PLA2G1B,Phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,34328,0.120879256193833,0.0626881796418916,-0.00198957590427422,0.243748088291941,0.0538511443162033
PLA2G1B,Phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34358,-0.0544466567592998,0.0769072160776979,-0.205184800271588,0.0962914867529882,0.478991406582929
PLA2G1B,Phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34276,-0.0370403080788541,0.0582225335755545,-0.151156473886941,0.0770758577292327,0.524670608967879
PLA2G1B,Phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34359,-0.0185515173928891,0.0653582724917734,-0.146653731476765,0.109550696690987,0.776536289021274
PLA2G1B,Phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34317,0.0665860683241372,0.0800723260821973,-0.0903556907969696,0.223527827445244,0.405669545337345
PLA2G1B,Phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34323,-0.00631378328506763,0.0799507278226934,-0.163017209817547,0.150389643247411,0.937057346703214
PLA2G1B,Phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,34353,0.0462651840691286,0.075736642827731,-0.102178635873224,0.194709004011481,0.54130018633099
PLA2G1B,Phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,34363,0.0157788196917771,0.054119952153934,-0.0902962865299336,0.121853925913488,0.770634725544257
PLA2G1B,Phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,34372,-0.0791138837407294,0.0478971404403859,-0.172992279003886,0.0147645115224269,0.0986181070235544
PLA2G1B,Phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,34378,-0.0726134157698728,0.0606096507915234,-0.191408331321259,0.0461814997815132,0.230926008869884
PLA2G1B,Phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34362,0.0458731063638682,0.0607778400962864,-0.0732514602248531,0.164997672952589,0.450406751515772
PLA2G1B,Phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,34377,-0.4259401687282,0.0410141747562396,-0.50632795125043,-0.345552386205971,3.89472804174593e-25
PLA2G1B,Phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33099,-0.385759473075711,0.0512775588312462,-0.486263488384954,-0.285255457766468,5.89103662884815e-14
PLA2G1B,Phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33116,-0.363290931704147,0.0523362261525458,-0.465869934963136,-0.260711928445157,4.15943141643628e-12
PLA2G1B,Phospholipase A2,Mental health,X29104.Ever used cannabis,34370,0.0651705646389051,0.0618151233704331,-0.0559870771671439,0.186328206444954,0.291779571001183
PLA2G1B,Phospholipase A2,Mental health,X29108.Ever thought that life not worth living,34314,-0.0603864569964433,0.0487189531725065,-0.155875605214556,0.0351026912216696,0.215195093549107
PLA2G1B,Phospholipase A2,Mental health,X29109.Ever contemplated self-harm,34351,0.0139865905588925,0.0645417218203206,-0.112515184208936,0.140488365326721,0.828441790723901
PLA2G1B,Phospholipase A2,Mental health,X29111.Ever self-harmed,34366,0.0661558424601683,0.100302290127338,-0.130436646189415,0.262748331109752,0.509548583226673
PLA2G1B,Phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34359,0.136518487072185,0.0673945859665161,0.0044250985778132,0.268611875566556,0.0428264388258936
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33937,0.0357500105958694,0.0398739498503917,-0.0424029311108983,0.113902952302637,0.369968176181854
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33937,0.0401116205868933,0.0304906029765656,-0.0196499612471753,0.099873202420962,0.188360140577184
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33937,0.0127406601850226,0.0308906071764603,-0.0478049298808396,0.0732862502508849,0.680022993754326
PLA2G1B,Phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33937,0.0331733245939632,0.0396856412759916,-0.0446105323069804,0.110957181494907,0.403230843014917
PLA2G1B,Phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34353,0.0662806533931946,0.0448576081041293,-0.0216402584908989,0.154201565277288,0.139552347019207
PLA2G1B,Phospholipase A2,Health and medical history,X29153.Pain or discomfort today,34365,-0.0134656197304195,0.04324798659787,-0.0982316734622448,0.0713004340014057,0.755534797940234
PLA2G1B,Phospholipase A2,Mental health,X29154.Anxiety or depression today,34365,0.022361010578649,0.0514125442081261,-0.0784075760692783,0.123129597226576,0.663620552657295
PLA2G1B,Phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,34114,-0.0671641080186185,0.0420586035816458,-0.149598971038644,0.0152707550014073,0.110316878173114
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34330,-0.00780845518597293,0.00971426703546492,-0.0268484185754842,0.0112315082035383,0.421524260487635
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34330,-0.000893677855422952,0.00952986426510919,-0.019572211815037,0.0177848561041911,0.925288556667075
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34330,-0.0539919811717192,0.013911920354805,-0.081259345067137,-0.0267246172763014,0.00010470989917576
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34330,0.0243519567934197,0.0121642774987642,0.00050997289584194,0.0481939406909975,0.0453202194734883
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34330,0.0182215291491348,0.0181292705925591,-0.017311841212281,0.0537548995105505,0.314878650541138
PLA2G1B,Phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34330,0.0129394647422416,0.00952633502350737,-0.00573215190383287,0.031611081388316,0.174404728296094
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34332,0.00463026906112662,0.0105933786567566,-0.0161327531061164,0.0253932912283696,0.662055003354921
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34332,-0.0194090158229404,0.0148448765862099,-0.0485049739319118,0.00968694228603099,0.191088476380903
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34332,-0.0736687176893379,0.0309436182521079,-0.134318209463469,-0.0130192259152064,0.0172967320992575
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34332,0.0143276938729491,0.0203772388122479,-0.0256116941990569,0.0542670819449551,0.481996016174307
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34332,-0.0225907344697359,0.0287797779747889,-0.0789990993003222,0.0338176303608503,0.432500732991777
PLA2G1B,Phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34332,0.0147870442155378,0.0150832924937865,-0.0147762090722838,0.0443502975033594,0.326932858020551
PLA2G1B,Phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34218,-0.00225335707168827,0.0522977626791876,-0.104756971922896,0.100250257779519,0.965633011739855
PLA2G1B,Phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,34305,0.0241745833262092,0.0464253552387009,-0.0668191129416446,0.115168279594063,0.602573957116948
PLA2G1B,Phospholipase A2,Mental health,X29173.Frequency of feeling left out,34243,-0.0336998248931357,0.0483262912206425,-0.128419355685595,0.0610197058993237,0.485607001844165
PLA2G1B,Phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,34275,-0.00434863114248996,0.0503426538214049,-0.103020232632444,0.0943229703474636,0.931165589522411
PLA2G1B,Phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,34350,-0.024955122317188,0.0421908441018289,-0.107649176756773,0.0577389321223966,0.554211064283841
PLA2G1B,Phospholipase A2,Mental health,X29176.Ability to make it through stressful events,34350,0.0278424885484045,0.0409996489056075,-0.0525168233065862,0.108201800403395,0.497096150244876
PLA2G1B,Phospholipase A2,Mental health,X29177.Quick recovery from stressful events,34350,-0.0246200383606598,0.0415254532054115,-0.106009926643266,0.0567698499219467,0.553268120259151
PLA2G1B,Phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,34350,0.0123482441291557,0.0411631522101849,-0.0683315342028066,0.093028022461118,0.76419645685069
PLA2G1B,Phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,34350,-0.0462068599277815,0.0416979845427243,-0.127934909631521,0.0355211897759582,0.26783186170584
PLA2G1B,Phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,34350,0.00292931974851542,0.0416395881091563,-0.078684272945431,0.0845429124424618,0.943916991559576
PLA2G1B,Phospholipase A2,Mental health,X29181.General happiness,34290,-0.0359696175119212,0.0434268827635702,-0.121086307728519,0.0491470727046763,0.407532059803195
PLA2G1B,Phospholipase A2,Mental health,X29182.Belief that own life is meaningful,34193,0.0167940043894028,0.0428740883888059,-0.0672392088526567,0.100827217631462,0.695284600937774
PLA2G1B,Phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29702,-0.0758014453096283,0.054239859821738,-0.182111570560235,0.0305086799409783,0.16231545270589
PLA2G1B,Phospholipase A2,Health and medical history,X2946.Father's age,30780,0.016579103937529,0.00864047332132248,-0.000356223772263103,0.033514431647321,0.0550580476244107
PLA2G1B,Phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,30420,-0.016189246113109,0.00776791857211973,-0.0314143665144637,-0.000964125711754324,0.0371920142552376
PLA2G1B,Phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51526,-0.0171779035014288,0.00302425947471374,-0.0231054520718677,-0.0112503549309898,1.36045716661289e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51526,0.0241245779389835,0.00354319486346507,0.017179916006592,0.031069239871375,1.00536097824539e-11
PLA2G1B,Phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51526,0.00409042712344572,0.00384750497605637,-0.00345068262962476,0.0116315368765162,0.287729047324398
PLA2G1B,Phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51526,0.0131364102995593,0.00373164784821927,0.00582238051704958,0.0204504400820691,0.000431814689546346
PLA2G1B,Phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51526,-0.0173387670309798,0.00297018246568188,-0.0231603246637163,-0.0115172093982434,5.35586153292462e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51525,-0.025223080636708,0.00297350017878026,-0.0310511409871174,-0.0193950202862987,2.31240955550483e-17
PLA2G1B,Phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51525,-0.0184431307471895,0.00291257140264797,-0.0241517706963795,-0.0127344907979995,2.45401310990115e-10
PLA2G1B,Phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51526,0.0144738783406338,0.00281196993714765,0.00896241726382439,0.0199853394174432,2.66196062342143e-07
PLA2G1B,Phospholipase A2,Blood and urine assays,X30080.Platelet count,51526,-0.0106746353243503,0.00297993285989525,-0.016515303729745,-0.00483396691895562,0.000341345162434378
PLA2G1B,Phospholipase A2,Blood and urine assays,X30090.Platelet crit,51526,-0.00935221671397908,0.00305233631347224,-0.0153347958883847,-0.00336963753957349,0.00218647456429314
PLA2G1B,Phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51526,0.00506132844360796,0.00288701452323735,-0.000597220021937243,0.0107198769091532,0.0795900205020468
PLA2G1B,Phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51526,-0.0045136568060636,0.00288413768092208,-0.0101665666606709,0.00113925304854368,0.117596114134613
PLA2G1B,Phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51486,-0.0129656267360747,0.00300484212469983,-0.0188551173004864,-0.00707613617166308,1.60233665222785e-05
PLA2G1B,Phospholipase A2,Blood and urine assays,X30130.Monocyte count,51486,-0.00679375201023959,0.0030493448846096,-0.0127704679840744,-0.000817036036404773,0.0258928302058861
PLA2G1B,Phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51486,-0.0162032929060665,0.00300161720216331,-0.0220864626223066,-0.0103201231898264,6.78838317123586e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51486,0.0037862383251515,0.00295924140102931,-0.00201387482086594,0.00958635147116895,0.200745226705666
PLA2G1B,Phospholipase A2,Blood and urine assays,X30160.Basophill count,51486,-0.0260434417187524,0.0261768163384489,-0.0773500017421122,0.0252631183046074,0.319791445481104
PLA2G1B,Phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51486,0.188910922426057,0.112995756076853,-0.0325607594845748,0.410382604336689,0.0945672798439768
PLA2G1B,Phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51486,0.00234112678705831,0.00296928402932827,-0.0034786699104251,0.00816092348454171,0.430441472929011
PLA2G1B,Phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51486,0.0056979135394715,0.00300723312945925,-0.000196263394268633,0.0115920904732116,0.0581380167577099
PLA2G1B,Phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51486,-0.00583887694529539,0.00294264616202845,-0.0116064634228712,-7.12904677196251e-05,0.0472406734701545
PLA2G1B,Phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51486,0.0108156278421028,0.0029261463204063,0.00508038105410648,0.0165508746300992,0.000219280951863527
PLA2G1B,Phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51486,-0.00109079881886855,0.0027987469213609,-0.00657634278473591,0.00439474514699882,0.696727870624118
PLA2G1B,Phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51486,0.190879761838564,0.112953267052785,-0.0305086415848958,0.412268165262023,0.0910585570565235
PLA2G1B,Phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,51039,-0.0337720524209138,0.00306344361949456,-0.0397764019151232,-0.0277677029267045,3.36201816914309e-28
PLA2G1B,Phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,51039,-0.0300498740602995,0.00316793382886901,-0.0362590243648828,-0.0238407237557162,2.60352451503342e-21
PLA2G1B,Phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,51039,-0.00635973576157409,0.00294336689941057,-0.0121287348844188,-0.000590736638729376,0.0307273473480624
PLA2G1B,Phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,51039,-0.0168532388172816,0.00297309537488416,-0.0226805057520545,-0.0110259718825086,1.45473380169988e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,51039,-0.0221845665957919,0.00310133576896636,-0.0282631847029659,-0.0161059484886178,8.69524499155552e-13
PLA2G1B,Phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51039,-0.0368747761714476,0.00314699081398649,-0.0430428781668611,-0.0307066741760341,1.24079729820985e-31
PLA2G1B,Phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,51039,-0.0342333152084177,0.00322977769747285,-0.0405636794954645,-0.0279029509213709,3.38722516962289e-26
PLA2G1B,Phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,32260,0.0206058917707728,0.0059991948975037,0.0088474697716655,0.03236431376988,0.00059612829502087
PLA2G1B,Phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51582,0.00528687276487965,0.00307275630853592,-0.000735729599850755,0.01130947512961,0.0853414395933912
PLA2G1B,Phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51529,0.00256097444345906,0.00285878462574322,-0.00304224342299765,0.00816419230991578,0.370353506717991
PLA2G1B,Phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51498,-0.0357982983437554,0.00300618208507126,-0.041690415230495,-0.0299061814570157,1.29391469205456e-32
PLA2G1B,Phospholipase A2,Blood and urine assays,X30600.Albumin,48731,0.00291272847284156,0.00315535018788742,-0.00327175789541778,0.0090972148411009,0.355960186680311
PLA2G1B,Phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,51125,-0.00078903267725482,0.00300049038472725,-0.00666999383132024,0.0050919284768106,0.792577346174868
PLA2G1B,Phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,51133,-0.0141043982624132,0.00312497147209025,-0.0202293423477101,-0.00797945417711633,6.40542761127019e-06
PLA2G1B,Phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,48516,-0.0185321199708095,0.00345801589052664,-0.0253098311162417,-0.0117544088253773,8.43703838537789e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,51025,-0.00893534533469641,0.00297979273902244,-0.0147757391031804,-0.00309495156621243,0.00271432598859434
PLA2G1B,Phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,51052,0.000684752745483517,0.00301901446488382,-0.00523251560568877,0.0066020210966558,0.820570635395903
PLA2G1B,Phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,45205,6.19116893474925e-05,0.00339859709597877,-0.00659933861877089,0.00672316199746587,0.985466045998906
PLA2G1B,Phospholipase A2,Blood and urine assays,X30670.Urea,51119,0.0743911842787866,0.00308247230499668,0.0683495385609931,0.0804328299965801,2.57815365086194e-127
PLA2G1B,Phospholipase A2,Blood and urine assays,X30680.Calcium,48738,0.0207462654265719,0.0030213973357681,0.0148243266484664,0.0266682042046774,6.7406783761198e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30690.Cholesterol,51133,-0.00302985805832174,0.00306891623544258,-0.0090449338797892,0.00298521776314572,0.323517788809371
PLA2G1B,Phospholipase A2,Blood and urine assays,X30700.Creatinine,51126,0.143324747009758,0.00328495499880757,0.136886235212096,0.149763258807421,0
PLA2G1B,Phospholipase A2,Blood and urine assays,X30710.C-reactive protein,51067,-0.0311970878555893,0.00327577985897116,-0.0376176163791727,-0.0247765593320058,1.81062888663112e-21
PLA2G1B,Phospholipase A2,Blood and urine assays,X30720.Cystatin C,51129,0.109309236426552,0.00327402850211657,0.102892140562403,0.1157263322907,1.81245854073159e-239
PLA2G1B,Phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,51129,-0.0347802108214039,0.00306149935310797,-0.0407807495534955,-0.0287796720893122,7.70105889836132e-30
PLA2G1B,Phospholipase A2,Blood and urine assays,X30740.Glucose,48711,-0.0539213500251688,0.00324735854415113,-0.060286172771705,-0.0475565272786326,1.41069623684288e-61
PLA2G1B,Phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50956,-0.0149258805099399,0.00333360886365146,-0.0214597538826967,-0.00839200713718301,7.58747041647642e-06
PLA2G1B,Phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,48724,0.000495892338771967,0.00364110846280418,-0.00664068024832422,0.00763246492586815,0.891670087111749
PLA2G1B,Phospholipase A2,Blood and urine assays,X30770.IGF-1,50982,0.046248360987187,0.00298686067693945,0.0403941140603856,0.0521026079139883,7.66479210001259e-54
PLA2G1B,Phospholipase A2,Blood and urine assays,X30780.LDL direct,51077,0.00157968450649683,0.00299026501961836,-0.00428123493195516,0.00744060394494881,0.59731236075248
PLA2G1B,Phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,45808,0.00819715351566133,0.00327145386279685,0.00178510394457951,0.0146092030867432,0.0122296626407957
PLA2G1B,Phospholipase A2,Blood and urine assays,X30810.Phosphate,48691,0.042814585178203,0.00324763466712933,0.0364492212306295,0.0491799491257765,1.49803772915053e-39
PLA2G1B,Phospholipase A2,Blood and urine assays,X30830.SHBG,48460,0.019766055107549,0.00343363688049042,0.0130361268217878,0.0264959833933102,8.6873106725897e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30840.Total bilirubin,51036,0.00493378747006051,0.00301202167259571,-0.000969775008227071,0.0108373499483481,0.101426882109355
PLA2G1B,Phospholipase A2,Blood and urine assays,X30850.Testosterone,46585,-0.031144954614189,0.00526107275553939,-0.0414566572150462,-0.0208332520133318,3.26914563341981e-09
PLA2G1B,Phospholipase A2,Blood and urine assays,X30860.Total protein,48729,0.0174299545137295,0.00307581660225803,0.0114013539733037,0.0234585550541552,1.47159987241018e-08
PLA2G1B,Phospholipase A2,Blood and urine assays,X30870.Triglycerides,51123,-0.0237015839655294,0.00332554857087726,-0.0302196591644488,-0.01718350876661,1.05095567444986e-12
PLA2G1B,Phospholipase A2,Blood and urine assays,X30880.Urate,51095,0.0293158829084509,0.00365140764541522,0.0221591239234371,0.0364726418934648,1.02583772809683e-15
PLA2G1B,Phospholipase A2,Blood and urine assays,X30890.Vitamin D,49578,0.0286245121027912,0.00327691571698543,0.0222017572974998,0.0350472669080827,2.58091674751707e-18
PLA2G1B,Phospholipase A2,Physical measures,X3137.Number of measurements made,49999,-0.0528636995267139,0.0297242497896262,-0.111123229114381,0.0053958300609535,0.0753385130067741
PLA2G1B,Phospholipase A2,Physical measures,X3143.Ankle spacing width,40356,-0.0155162880231066,0.00517140492528002,-0.0256522416766554,-0.00538033436955772,0.00270042288664915
PLA2G1B,Phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40355,-0.00545324540774613,0.004194930969979,-0.013675310108905,0.00276881929341272,0.193633279436069
PLA2G1B,Phospholipase A2,Physical measures,X3146.Speed of sound through heel,40356,0.00287290766636603,0.00404446701747823,-0.0050542476878913,0.0108000630206234,0.47750971963518
PLA2G1B,Phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40356,1.29152596884231e-05,0.00409553488171941,-0.00801433310848162,0.00804016362785846,0.997483916622147
PLA2G1B,Phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),40354,-0.000160754700235654,0.00408480767826814,-0.00816697774964121,0.0078454683491699,0.968608418097232
PLA2G1B,Phospholipase A2,Health and medical history,X3526.Mother's age at death,41074,0.00405340100458945,0.00389112097861962,-0.00357319611350501,0.0116799981226839,0.297563522530584
PLA2G1B,Phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),40448,0.00338920329272416,0.00380643148631759,-0.00407140242045832,0.0108498090059066,0.3732706399378
PLA2G1B,Phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30236,-1.94926460028274e-05,0.00630644020169786,-0.0123801154413306,0.012341130149325,0.99753392027723
PLA2G1B,Phospholipase A2,Physical measures,X4100.Ankle spacing width (left),33442,-0.00998051672539223,0.0066395603150281,-0.0229940549428473,0.00303302149206284,0.132825334340144
PLA2G1B,Phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33440,0.000232243983113836,0.00543940054059331,-0.010428981076449,0.0108934690426767,0.965944327480528
PLA2G1B,Phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),33442,0.01258996408426,0.00529659399241053,0.00220863985913536,0.0229712883093846,0.0174752486624616
PLA2G1B,Phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33442,0.00891443761509277,0.00534270791462736,-0.00155726989757685,0.0193861451277624,0.0952465288070932
PLA2G1B,Phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),33440,0.00899401205054177,0.00532759228142898,-0.00144806882105902,0.0194360929221426,0.0914085883034554
PLA2G1B,Phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33442,0.00891407352840863,0.00534240709446441,-0.00155704437674161,0.0193851914335589,0.0952414114209148
PLA2G1B,Phospholipase A2,Physical measures,X4119.Ankle spacing width (right),33444,-0.012923654262491,0.00654817174785356,-0.025758070888284,-8.92376366980405e-05,0.0484546388216374
PLA2G1B,Phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33444,0.00336562018790021,0.00543660040979297,-0.007290116615294,0.0140213569910944,0.535887870728823
PLA2G1B,Phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),33444,0.0110305054429744,0.00531019265419343,0.000622527840755222,0.0214384830451935,0.0378084121822041
PLA2G1B,Phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33444,0.00856930786927671,0.00534927327187952,-0.00191526774360715,0.0190538834821606,0.109200157083511
PLA2G1B,Phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),33441,0.00917346945052256,0.00533788290620748,-0.00128878104564409,0.0196357199466892,0.0857290421194591
PLA2G1B,Phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33444,0.00856941810767966,0.00534929355296095,-0.0019151972561238,0.0190540334714831,0.109196942824978
PLA2G1B,Phospholipase A2,Physical measures,X4194.Pulse rate,33706,-0.0388501896792108,0.0051776271472675,-0.0489983388878551,-0.0287020404705665,6.78856933144524e-14
PLA2G1B,Phospholipase A2,Physical measures,X4195.Pulse wave reflection index,33706,0.00918422993429338,0.00520445126549845,-0.00101649454608358,0.0193849544146703,0.0776492874713371
PLA2G1B,Phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,33703,0.0150079451669309,0.00474879047743834,0.00570031583115179,0.0243155745027101,0.00158075769207475
PLA2G1B,Phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,33706,-0.0213388490144072,0.00459224747980416,-0.0303396540748233,-0.012338043953991,3.41927925573888e-06
PLA2G1B,Phospholipase A2,Physical measures,X4199.Position of pulse wave notch,33706,-0.0226838611580905,0.00511467277707903,-0.0327086198011654,-0.0126591025150156,9.31110775021398e-06
PLA2G1B,Phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33706,-0.0167867919653506,0.00458874273003692,-0.025780727716223,-0.00779285621447826,0.000255348783999841
PLA2G1B,Phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),33605,-0.136353163739213,0.132328707036188,-0.395717429530142,0.123011102051716,0.30284364119533
PLA2G1B,Phospholipase A2,Physical measures,X4270.Volume level set by participant (left),33518,-0.0274804761454539,0.0416709260207629,-0.109155491146149,0.0541945388552414,0.509614603259424
PLA2G1B,Phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),33607,-0.0220345748405407,0.12700572732645,-0.270965800400382,0.226896650719301,0.862267955238006
PLA2G1B,Phospholipase A2,Physical measures,X4277.Volume level set by participant (right),33496,0.0574113352964737,0.0418764873806133,-0.0246665799695283,0.139489250562476,0.170418878889893
PLA2G1B,Phospholipase A2,Cognitive function,X4288.Time to answer,33777,0.0134804204528718,0.00581068611805386,0.00209147566148621,0.0248693652442574,0.0203658146632418
PLA2G1B,Phospholipase A2,Cognitive function,X4290.Duration screen displayed,33777,0.000504695583620223,0.00515825964524881,-0.00960549332106744,0.0106148844883079,0.922059683025885
PLA2G1B,Phospholipase A2,Physical measures,X46.Hand grip strength (left),52354,-0.00877198254261534,0.00434569775712888,-0.017289550146588,-0.000254414938642736,0.0435441747961568
PLA2G1B,Phospholipase A2,Physical measures,X47.Hand grip strength (right),52359,-0.00582859466850364,0.0043214936883819,-0.0142987222977322,0.00264153296072488,0.177429706780041
PLA2G1B,Phospholipase A2,Physical measures,X48.Waist circumference,52446,-0.0845548167618318,0.00576213030210628,-0.0958485921539601,-0.0732610413697035,1.42892246766421e-48
PLA2G1B,Phospholipase A2,Health and medical history,X4803.Tinnitus,33613,0.0217230659703966,0.0498952713507253,-0.0760716658770251,0.119517797817818,0.663301790905717
PLA2G1B,Phospholipase A2,Working and living environment,X4825.Noisy workplace,33750,-0.0365147826849525,0.0710299204416682,-0.175733426750622,0.102703861380717,0.607211023720164
PLA2G1B,Phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,33693,-0.0345663253469604,0.0837933557332574,-0.198801302584145,0.129668651890224,0.679968856164601
PLA2G1B,Phospholipase A2,Physical measures,X49.Hip circumference,52443,-0.000430361817466543,0.00490511571664732,-0.0100443886220953,0.00918366498716221,0.930086066686376
PLA2G1B,Phospholipase A2,Physical measures,X50.Standing height,52441,-0.0232539060809879,0.00401423017550709,-0.0311217972249818,-0.015386014936994,6.99347507680017e-09
PLA2G1B,Phospholipase A2,Health and medical history,X5057.Number of older siblings,32666,0.0644468916488036,0.044556254195314,-0.0228833665740119,0.151777149871619,0.148098637882213
PLA2G1B,Phospholipase A2,Physical measures,X51.Seated height,52313,-0.0108820734462905,0.0040345713535647,-0.0187898332992773,-0.0029743135933037,0.0069965885033413
PLA2G1B,Phospholipase A2,Eye measures,X5181.Ever had eye surgery,30734,-0.204803247787223,0.0988220660526207,-0.398494497250359,-0.011111998324086,0.0382647130554204
PLA2G1B,Phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30716,-0.0101434045913237,0.0060012557474387,-0.0219058658563035,0.00161905667365617,0.0910368371475247
PLA2G1B,Phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30718,-0.000861049675423337,0.00593895807546325,-0.0125014075033313,0.0107793081524846,0.884728728801945
PLA2G1B,Phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),30643,0.0020407246372622,0.00599812738851818,-0.00971560504423344,0.0137970543187578,0.733697160810588
PLA2G1B,Phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),30644,-7.51530753563463e-05,0.00603483183738877,-0.0119034234766383,0.0117531173259256,0.990064427783886
PLA2G1B,Phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",30697,-0.0298452350312258,0.052764087767401,-0.133262847055332,0.0735723769928802,0.571661993717824
PLA2G1B,Phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),30697,0.0269872110921395,0.377891183061633,-0.713679507708661,0.76765392989294,0.943069522959405
PLA2G1B,Phospholipase A2,Eye measures,"X5201.logMAR, final (right)",30647,-0.00469371870271562,0.00626463484138555,-0.0169724029918313,0.00758496558640007,0.453740656708943
PLA2G1B,Phospholipase A2,Eye measures,X5202.Number of rounds to result (right),30697,-0.0393577040867906,0.0492522399195525,-0.135892094329113,0.0571766861555322,0.424260058306808
PLA2G1B,Phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",30696,-0.0598358153914891,0.0526382949280707,-0.163006873450508,0.0433352426675294,0.255692528662252
PLA2G1B,Phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),30696,0.0970313363691286,0.304928910322719,-0.500629327863401,0.694692000601658,0.750336522500393
PLA2G1B,Phospholipase A2,Eye measures,"X5208.logMAR, final (left)",30632,-0.00869087528265253,0.00619370268540976,-0.0208305325460557,0.0034487819807506,0.16061362330271
PLA2G1B,Phospholipase A2,Eye measures,X5209.Number of rounds to result (left),30694,0.00840028170729354,0.0492288969494933,-0.0880883563137133,0.1048889197283,0.864514576612181
PLA2G1B,Phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30396,0.0109433474362885,0.00610966453266969,-0.00103159504774409,0.0229182899203211,0.0733195152154876
PLA2G1B,Phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30396,0.00365641523986365,0.00616018078111326,-0.00841753909111835,0.0157303695708456,0.552831379384419
PLA2G1B,Phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),30396,-0.0101204860662169,0.00612149762534692,-0.0221186214118969,0.00187764927946301,0.0983288109502631
PLA2G1B,Phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),30396,-0.00616144517010016,0.00613426397992204,-0.0181846025707474,0.00586171223054704,0.315211779804971
PLA2G1B,Phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30394,0.00107589196937341,0.00611433676711788,-0.0109082080941776,0.0130599920329245,0.860329658363353
PLA2G1B,Phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30394,0.00519139834823855,0.00608721723845856,-0.00673954743914024,0.0171223441356173,0.393784599669687
PLA2G1B,Phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),30394,0.00415965382836767,0.00624159461406027,-0.00807387161519046,0.0163931792719258,0.505155211859619
PLA2G1B,Phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),30394,0.00584137180462253,0.00617597805230397,-0.00626354517789324,0.0179462887871383,0.344278180748085
PLA2G1B,Phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29971,0.058095206010025,0.233888791755838,-0.400326825831417,0.516517237851467,0.803843338789172
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52352,-0.00163658937019631,0.0169084869986316,-0.0347772238875142,0.0315040451471216,0.922893066318101
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52352,-0.0349991517925156,0.0173667158200372,-0.0690379147997885,-0.000960388785242565,0.043882739484569
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52352,0.126144044797162,0.0443104191821059,0.0392956232002349,0.21299246639409,0.00441897369826113
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52352,-0.0267756991380006,0.00736558715159431,-0.0412122499551254,-0.0123391483208757,0.00027821786308611
PLA2G1B,Phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52352,0.0278481110762623,0.00673182144604973,0.0146537410420048,0.0410424811105198,3.53234060987071e-05
PLA2G1B,Phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37378,0.00877135883169179,0.00853942273762033,-0.00796590973404405,0.0255086273974276,0.304364054159259
PLA2G1B,Phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37378,-0.0243311746616308,0.0213538446124852,-0.0661847101021017,0.0175223607788402,0.254545676235032
PLA2G1B,Phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37378,-0.00988453383253574,0.0166687228963163,-0.0425552307093157,0.0227861630442442,0.553192283394737
PLA2G1B,Phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37378,-0.0183467345463374,0.0102643900792687,-0.0384649391017041,0.00177147000902924,0.073893706648005
PLA2G1B,Phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52437,-0.00795468145000435,0.0138534233590817,-0.0351073912338046,0.0191980283337959,0.565834849562778
PLA2G1B,Phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52437,-0.00795468145000435,0.0138534233590817,-0.0351073912338046,0.0191980283337959,0.565834849562778
PLA2G1B,Phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52437,-0.00320749844356332,0.0110934958352324,-0.0249507502806188,0.0185357533934921,0.772481555823499
PLA2G1B,Phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52437,0.0234065047781515,0.0173192404424831,-0.0105392064891154,0.0573522160454184,0.176554537345663
PLA2G1B,Phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52437,-0.0832406296822367,0.0431031816004703,-0.167722865619158,0.00124160625468499,0.0534690836067039
PLA2G1B,Phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52437,3.92726708027075e-05,0.0292272509178076,-0.0572461391281002,0.0573246844697056,0.998927892040636
PLA2G1B,Phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52437,-0.0594879413539621,0.0476301315502699,-0.152842999192491,0.0338671164845669,0.211691593247529
PLA2G1B,Phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52352,0.00822002002103472,0.0089100844738566,-0.00924374554772421,0.0256837855897937,0.356248476879626
PLA2G1B,Phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52352,-0.0208628554698163,0.0148945321146089,-0.0500561384144498,0.00833042747481716,0.161313230271738
PLA2G1B,Phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52352,-0.0125979778380034,0.0079040193628389,-0.0280898557891677,0.00289390011316083,0.11097652518256
PLA2G1B,Phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52352,0.0167298130961384,0.0146325323794824,-0.0119499503676472,0.045409576559924,0.252911418100122
PLA2G1B,Phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52352,-0.000342658181505687,0.0142802611857388,-0.0283319701055538,0.0276466537425424,0.980856583454371
PLA2G1B,Phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52352,-0.0122170008264894,0.00800336849603056,-0.0279036030787093,0.00346960142573054,0.126901115941587
PLA2G1B,Phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31933,0.0453255813226841,0.0327299095320045,-0.0188250413600447,0.109476204005413,0.166143689812031
PLA2G1B,Phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31933,0.0109368761360115,0.0215683748423456,-0.0313371385549857,0.0532108908270088,0.61211413397981
PLA2G1B,Phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31933,0.0726913796704918,0.0277514236708129,0.0182985892756985,0.127084170065285,0.00882688962650793
PLA2G1B,Phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31933,-0.0179364435056556,0.0245245005693458,-0.0660044646215734,0.0301315776102621,0.464577099454078
PLA2G1B,Phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52348,-0.0412675094515615,0.0217239356447494,-0.0838464233152704,0.00131140441214736,0.0574915752195883
PLA2G1B,Phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52348,-0.0369300255773294,0.036938702474462,-0.109329882427275,0.0354698312726162,0.317432870921249
PLA2G1B,Phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52348,-0.00893628849542131,0.0594817239111985,-0.12552046736137,0.107647890370528,0.88057961365732
PLA2G1B,Phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52348,-0.0269859422022857,0.0580940143106974,-0.140850210251253,0.0868783258466813,0.642277494498158
PLA2G1B,Phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52348,0.00194072152084106,0.0181878526659029,-0.0337074697043285,0.0375889127460107,0.915024363180222
PLA2G1B,Phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52348,-0.0284170386274366,0.0259379974189431,-0.0792555135685649,0.0224214363136918,0.273273976866523
PLA2G1B,Phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52348,-0.0158701444731887,0.012857505998433,-0.0410708562301174,0.00933056728373996,0.217097917532365
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34031,-0.0396257056606047,0.0193711113002577,-0.0775930838091098,-0.00165832751209967,0.0408221821764922
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34031,-0.0212847789029057,0.0224910529046839,-0.0653672425960862,0.0227976847902748,0.343985559874868
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34031,0.0255137331442989,0.0293310658786466,-0.0319751559778484,0.0830026222664462,0.384402213158476
PLA2G1B,Phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34031,-0.0178319905837628,0.0101223800739148,-0.0376718555286359,0.00200787436111024,0.0781620208679226
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37662,0.00930273117259377,0.0106093675197973,-0.011491629166209,0.0300970915113965,0.380588810614452
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37662,0.00145690888338337,0.00926436064049619,-0.0167012379719892,0.0196150557387559,0.875042727069901
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37662,-0.00631415360260499,0.00868586345806151,-0.0233384459804055,0.0107101387751956,0.467271924745765
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37662,-0.00356961669362353,0.0208594213568469,-0.0444540825530435,0.0373148491657964,0.864126282258726
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37662,-0.0316102080876651,0.0125221232893297,-0.0561535697347513,-0.00706684644057894,0.0116028991203627
PLA2G1B,Phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37662,-0.0389046851452783,0.0145186916692759,-0.0673613208170591,-0.0104480494734976,0.00737954897966815
PLA2G1B,Phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52352,0.00121505998567415,0.0194902584104806,-0.0369858464988677,0.039415966470216,0.950290998544716
PLA2G1B,Phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52352,-0.0116883803530025,0.0124882755600519,-0.0361654004507043,0.0127886397446992,0.349307905129002
PLA2G1B,Phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52352,-0.017412540005546,0.0482996490901677,-0.112079852222275,0.0772547722111826,0.718467990205087
PLA2G1B,Phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52352,0.00893445455359307,0.0123186502531703,-0.0152100999426208,0.0330790090498069,0.468287157509347
PLA2G1B,Phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52352,-0.0122938304104145,0.0147717019340682,-0.0412463662011883,0.0166587053803592,0.405271857434498
PLA2G1B,Phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52352,-0.00415679292939831,0.0165833923324263,-0.0366602419009538,0.0283466560421572,0.802078843622743
PLA2G1B,Phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52352,0.0115156369166545,0.00588078089226948,-1.06936321937045e-05,0.0230419674655027,0.0502186581588751
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28876,-0.00140206247293926,0.0199597085133642,-0.0405230911591331,0.0377189662132546,0.944002121302444
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28876,-0.0222739394534363,0.026329099411003,-0.0738789742990022,0.0293310953921296,0.397608629975876
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28876,0.00117915633633528,0.0174597840736456,-0.0330420204480101,0.0354003331206807,0.94615840317547
PLA2G1B,Phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28876,-0.0144140903073117,0.0157928101125616,-0.0453679981279324,0.0165398175133089,0.361450315443688
PLA2G1B,Phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52479,0.00516900672855599,0.00671891121100135,-0.00800005924500665,0.0183380727021186,0.441708617640465
PLA2G1B,Phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52479,-0.033621164993709,0.0180302553296256,-0.0689604654397752,0.00171813545235709,0.062232760512753
PLA2G1B,Phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52479,-0.00189067008949951,0.0065554193666179,-0.0147392920480706,0.0109579518690716,0.773032525987325
PLA2G1B,Phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52479,-0.00364639500951712,0.00653749183812609,-0.0164598790122443,0.00916708899321002,0.577008184384381
PLA2G1B,Phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52479,-0.0076457846267563,0.00944514858562582,-0.0261582758545829,0.0108667066010703,0.418238319427
PLA2G1B,Phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52479,0.00407322801089296,0.00835424833409139,-0.0123010987239262,0.0204475547457121,0.625862744776085
PLA2G1B,Phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52479,-0.00135934092737007,0.00700788433779506,-0.0150947942294484,0.0123761123747082,0.846198364343354
PLA2G1B,Phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52479,-0.0201761438992074,0.0190391309872479,-0.0574928406342133,0.0171405528357984,0.289281228991059
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43737,-0.00152840601570021,0.00687965861123529,-0.0150125368937214,0.011955724862321,0.82418930114397
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43737,-0.0437868810032978,0.00761891332925837,-0.0587199511286442,-0.0288538108779514,9.21404557466209e-09
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43737,0.0171496627282896,0.00765785930476981,0.00214025849094082,0.0321590669656385,0.0251357129842397
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43737,0.002106771781495,0.00979970429763031,-0.0171006486418604,0.0213141922048504,0.829782690634442
PLA2G1B,Phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43737,0.0173663367726227,0.00692710160609024,0.00378921762468585,0.0309434559205596,0.0121837651562565
PLA2G1B,Phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52229,-0.00725731509893325,0.00707589052932277,-0.0211260605364059,0.00661143033853938,0.30507032135206
PLA2G1B,Phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52229,0.0109439476715363,0.00569013925185295,-0.000208725262095501,0.022096620605168,0.0544503255952003
PLA2G1B,Phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52229,-0.00760320401876067,0.00622554630811671,-0.0198052747826694,0.00459886674514807,0.221986204547336
PLA2G1B,Phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52229,0.0142300845896353,0.0136974830699112,-0.0126169822273906,0.0410771514066612,0.298868118896955
PLA2G1B,Phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52241,0.00557387391434255,0.0064324647292494,-0.00703375695498628,0.0181815047836714,0.386211302713944
PLA2G1B,Phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52241,0.00661097986818842,0.0115428140509546,-0.0160129356716826,0.0292348954080594,0.566828401952746
PLA2G1B,Phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52352,-0.00631306809809763,0.00614822306601337,-0.0183635853074838,0.00573744911128858,0.304517985895685
PLA2G1B,Phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52352,-0.00422056783443705,0.00698220772741571,-0.0179056949801718,0.00946455931129773,0.545533008612086
PLA2G1B,Phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52352,0.00776502999038136,0.00912838689048205,-0.0101266083149634,0.0256566682957262,0.394973073118489
PLA2G1B,Phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52352,0.0097376184503801,0.0131570610685262,-0.0160502212439312,0.0355254581446914,0.459241970036504
PLA2G1B,Phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52352,0.0109762652302784,0.0135719745415148,-0.0156248048710907,0.0375773353316474,0.418668790371684
PLA2G1B,Phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52352,-0.011281559902654,0.0175634630476011,-0.0457059474759521,0.023142827670644,0.520663452836347
PLA2G1B,Phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40356,1.26401744323799e-05,0.00409552353762806,-0.00801458595931861,0.00803986630818337,0.997537500300921
PLA2G1B,Phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51832,0.00273734543908174,0.0237277336307383,-0.0437690124771652,0.0492437033553287,0.908156817861218
PLA2G1B,Phospholipase A2,Physical activities,X874.Duration of walks,47711,-0.000117155720080516,0.00313842542072432,-0.00626846954470018,0.00603415810453915,0.970222638091714
PLA2G1B,Phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50750,-0.0164361422871745,0.023228639992178,-0.0619642766718433,0.0290919920974943,0.479211821348199
PLA2G1B,Phospholipase A2,Physical activities,X894.Duration of moderate activity,44508,-0.0668606715171315,0.0287881861087003,-0.123285516290184,-0.0104358267440789,0.0202157811608805
PLA2G1B,Phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30529,0.0200855612265633,0.00631781877307964,0.00770263643132724,0.0324684860217994,0.00148427308762441
PLA2G1B,Phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50734,0.0153429411799458,0.0240121799434208,-0.031720931509159,0.0624068138690507,0.522851308016416
PLA2G1B,Phospholipase A2,Physical activities,X914.Duration of vigorous activity,38296,0.00565239579270415,0.00408212349963179,-0.00234856626657416,0.0136533578519825,0.166175573206084
